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Abstract 36 
Many aquatic pollutants can be present at low concentrations, but their mixtures can still affect health 37 
or behavior of exposed organisms. In this study, toxicological and chemical analyses were combined 38 
for spatial contamination profiling using an innovative passive sampling approach. A novel Dynamic 39 
2 
 
Passive Sampler (DPS) was employed as a mobile sampler from a ship cruising along 2130 km of the 40 
Danube river during the Joint Danube Survey 3 (JDS3). The sampling was performed in eight 41 
subsequent river stretches with two types of complementary passive samplers: silicone rubber sheets 42 
(SR) used for non-polar chemicals and SDB-RPS Empore™ disks (ED) for more hydrophilic compounds. 43 
Besides extensive chemical analyses, the bioactivity of samples was characterized by a battery of 44 
reporter gene bioassays. Cross-calibration of the employed passive samplers enabled robust 45 
estimation of water concentrations applicable for compounds with a wide range of physicochemical 46 
properties. DPS was suitable for sampling of water contaminants even at pg L-1 levels, with 209 of 267 47 
analyzed compounds detected in the samples. Biological effects were detected in both ED and SR 48 
extracts across all river stretches by bioassays focused on xenobiotic metabolism mediated by the aryl 49 
hydrocarbon and pregnane X receptors, endocrine disruptive potential mediated by estrogen and 50 
androgen receptors and the oxidative stress response. The bioassay responses expressed as 51 
bioanalytical equivalent concentrations (BEQbio) were comparable with data obtained from large 52 
volume active sampling. The extracts of the ED samplers were more biologically active than extracts of 53 
SR samplers. Except of estrogenicity, where the analyzed chemicals explained on average 62 % of the 54 
effects in ED samples, the detected chemicals explained less than 8 % of BEQbio values. The study shows 55 
the utility of the combination of the innovative passive sampling approach with effect-based tools for 56 
efficient and fast monitoring even in water bodies with relatively low levels of contamination.   57 
 58 
1. Introduction 59 
Contamination of river water with complex mixtures of organic micropollutants poses a challenge for 60 
current pollution monitoring. Monitoring programs are typically driven by a need to protect aquatic 61 
organisms and, in an indirect way, also human populations from potentially toxic effects of 62 
environmental pollutants. This is complicated by the fact that pollutants are mostly present in very 63 
complex mixtures and their biological effects are the outcome of the integrated effects of many 64 
individual chemicals (Escher and Leusch, 2012). Because these mixtures can consist of thousands of 65 
chemicals whose toxic properties are often not known, targeted chemical analysis of individual 66 
compounds can sufficiently describe neither their composition nor toxic properties (Neale et al., 67 
2015a). It has been previously shown that this problem could be addressed using a bioanalytical 68 
approach such as in vitro bioassays (Escher and Leusch, 2012; Giesy et al., 2002). These bioassays 69 
present rapid, sensitive and relatively inexpensive detection tools, which provide complementary 70 
information to data from instrumental chemical analysis. They enable estimation of the overall 71 
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biological activities of compounds present in environmental mixtures covering potential interactions 72 
among chemicals. 73 
In order to cover a wide range of possible adverse effects, the bioassay battery should include 74 
endpoints reflecting a diverse set of possible toxic mechanisms, such as initiation of xenobiotic 75 
metabolism, endocrine disruptive potential and adaptive stress responses (Escher et al., 2014). To 76 
describe the overall bioactive potential of mixtures of chemicals, the concept of bioanalytical 77 
equivalent concentration (BEQ) was developed ( Villeneuve et al., 2000; Baston and Denison, 2011). In 78 
this concept, the bioassay-detected biological potential of a complex mixture of chemicals is expressed 79 
as a concentration of a reference compound that would elicit the same effect as the mixture (BEQbio). 80 
To estimate the impact of detected chemicals, a comparable equivalent (BEQchem) can be modeled 81 
based on measured concentrations of individual chemicals using the concentration addition concept. 82 
Thus, by comparison of BEQchem with the equivalents detected in bioassays (BEQbio), it is possible to 83 
identify the chemicals most significantly contributing to the effect detected by bioassays (König et al., 84 
2016; Neale et al., 2015a, 2017a). 85 
Another challenge in aquatic pollutant monitoring is related to the requirement of a representative 86 
sampling in temporally and spatially variable water streams. Since concentrations of pollutants tend 87 
to fluctuate, frequent spot sampling or continuous sampling is required to provide a representative 88 
sample. This type of sampling is often laborious and resource-intensive. Many of the potentially toxic 89 
chemicals are present at very low concentrations and the effective pre-concentration step is thus 90 
needed prior to their instrumental analysis.  91 
These problems can be effectively addressed using integrative passive sampling. In this approach, 92 
samplers spontaneously absorb or adsorb chemicals from water. The integrative concentration of 93 
chemicals in a passive sampler throughout the sampling period decreases their limit of detection. It 94 
also allows estimation of their time-weighted average concentrations, which include residues from 95 
episodic pollution events often not detectable even using frequent spot sampling. As the uptake of 96 
pollutants by the passive samplers is affected by environmental variables such as temperature and 97 
flow velocity, accurate in situ assessment of water volume sampled during exposure is required. For 98 
individual compounds, estimation of sampled water volume can be performed through the application 99 
of performance reference compounds (PRCs) and models that relate the sampling rate to properties 100 
that control the compound mass transfer (Booij et al., 2007).  101 
Passive sampling as well as effect-based approaches are being considered as potentially suitable tools 102 
that could be employed for monitoring of European water bodies in the implementation strategy of 103 
the EU Water Framework Directive (European Comission, 2015). While both approaches are often 104 
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employed independently, the utility of their combination has been demonstrated previously in studies 105 
focusing on small water streams and wastewater treatment plant effluents and affected rivers (Creusot 106 
et al., 2013; Jalova et al., 2013; Jarosova et al., 2012). However, these approaches have not been 107 
validated for large rivers with moderate or low levels of contamination.  108 
This study investigates the applicability of the newly developed dynamic passive sampling (DPS), which 109 
speeds up the uptake of compounds, for pollution and toxicity profiling of large rivers.  The DPS was 110 
employed in the Joint Danube Survey 3 (JDS3) as a mobile sampler from a ship cruising downstream 111 
along 2130 km of the Danube river, one of the largest rivers in Europe. The relatively low contamination 112 
level makes the Danube suitable for testing of sampling techniques for monitoring of less concentrated 113 
pollutants. The sampling was performed in eight subsequent river stretches with two types of 114 
complementary passive samplers: partitioning silicone rubber sheets (SR) focused on non-polar 115 
chemicals, which allow quantification of sampling rate, and adsorption SDB-RPS Empore™ disks (ED) 116 
for non-polar as well as more hydrophilic compounds. Besides extensive chemical analyses, sample 117 
extracts were characterized by a battery of in vitro bioassays covering a range of endpoint types 118 
including endocrine disruption, xenobiotic metabolism, and adaptive stress responses. BEQ modeling 119 
was used to estimate the portion of biological effects of the samples that can be explained by detected 120 
chemicals. Since the same bioassays were used also for the assessment of samples from large volume 121 
active sampling during the JDS3 ship cruise (Neale et al., 2015a), it allowed for a mutual comparison of 122 
passive and active sampling approaches for toxicity profiling.  123 
 124 
2. Material and methods 125 
2.1. Passive sampling  126 
Sample collection was performed during the JDS3 (Liska et al., 2015) on a sampling cruise in August 127 
and September 2013 using a dynamic passive sampling (DPS) system described by Vrana et al. 128 
(submitted). Briefly, the DPS device consisted of a stainless-steel chamber equipped with a submersible 129 
pump (approx. 9 m3 h-1) that provided a forced flow of sampled water through the sampling chamber 130 
with a current velocity of 1–2 m s-1. For mobile sampling, the device was immersed in a flow-through 131 
tank located on the frontal deck of the JDS3 expedition ship (Vrana et al., submitted). Each individual 132 
sampling period lasted approximately five days, which resulted in a total of eight samples collected 133 
from each sampler type representing eight stretches of the Danube River (Tab. S1). Two parallel DPS 134 
devices were in operation during each sampler deployment. The samplers exposed in one of the 135 
devices were dedicated to chemical analyses and the samplers from the other device were used for 136 
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bioanalyses. Besides sampling from the ship, stationary DPS was also performed at a site located at 137 
the Danube river kilometer 1852, approximately 15 km downstream of Bratislava (Fig. 1) and the 138 
sampling dates coincided with time periods when the JDS3 expedition ship moved by the stationary 139 
site. 140 
Two types of passive samplers were utilized for bioanalysis: silicone rubber (SR) AlteSil™ sheets, and 141 
SDB-RPS Empore™ disks (ED) based on styrene-divinylbenzene sorbent modified with sulfonic acid 142 
groups. 143 
AlteSil™ translucent SR sheets 0.5 mm thick were purchased from Altec, UK. The sampler consisted of 144 
a single AlteSil™ SR sheet with dimensions 14×28 cm. SR samplers in the DPS device dedicated for 145 
chemical analyses were spiked prior to exposure with a set of PRCs. The ED sampler consisted of ten 146 
solid phase Empore™ SDB-RPS extraction disks with 47 mm diameter (Sigma Aldrich, Czech Republic). 147 
ED samplers were not spiked with any PRCs. 148 
 Besides SR and ED samplers, the DPS devices were equipped with a reference passive sampler that 149 
served to compare the sampling performance of the two DPS devices operating in parallel. It consisted 150 
of a strip of low-density polyethylene (LDPE; 4×28 cm and 70 µm thickness; Brentwood Plastics Inc, 151 
USA). The LDPE samplers mounted in both DPS devices were spiked with another set of PRCs. The LDPE 152 
samplers were located sideways from the SR and ED samplers to minimize cross-contamination of the 153 
samplers by PRCs, for further detailed information on sampling, list of PRCs and sample processing see 154 
SI1 and Vrana et al. (submitted). 155 
 156 
 157 
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Fig. 1 Map of the sampling cruise with the stretches and stationary exposure site (red dot)  158 
 159 
2.2. Chemical analysis 160 
SR and ED were processed as described in the SI (1.1.1-1.1.2). SR extracts were analyzed for 81 161 
hydrophobic compounds from the following groups: polycyclic aromatic hydrocarbons (PAHs; 29 162 
individual chemicals), PCBs (7), organochlorine pesticides and their degradation products (OCPs; 12), 163 
brominated diphenyl ethers (PBDEs; 9) and novel brominated flame retardants (15), alkylphenols (3), 164 
alkyl- and aryl- phosphates (14), and synthetic musks (6). ED extracts were analyzed for 204 chemicals 165 
from the following groups: currently used pesticides (CUPs; 40), steroids (5), phytosterols (11), 166 
flavonoids (8), alkylphenols (3), pharmaceuticals (108) and PAHs (29). For a comprehensive list of 167 
analyzed compounds see SI (Tab.S2, S3).  168 
PAHs were analyzed by gas chromatography/mass spectrometry (GC/MS) using GC 7890/MS5975 169 
(Agilent, USA) equipped with J&W Scientific fused silica column DB-5MS (0.25 mm I.D., film thickness: 170 
0.25 μm; Agilent). For PCBs and OCPs, the analysis was performed using GC 7890/MS-MS Triple 171 
Quadrupole 7000B (Agilent), equipped with HT8 SGE Analytical Science column. PBDEs were analyzed 172 
by GC 7890A (Agilent) equipped with 15m × 0.25mm × 0.10 μm RTX-1614 column (Restek, USA), HRMS 173 
(AutoSpec Premier) was operated in EI+ mode at the resolution of >10,000. Alkylphenols were 174 
derivatized with dansyl chloride, separated using an Agilent 1200 Infinity Series liquid chromatograph 175 
equipped with an ACE 5 C18 column (ACE, UK) and detected by MS/MS Agilent 6410 Triple Quadrupole 176 
(Pernica et al., 2015). Novel brominated flame retardants were analyzed using  GC 7890A (Agilent) 177 
equipped with 15 m × 0.25 mm × 0.10 μm DB5 column coupled to an AutoSpec Premier MS (Waters, 178 
Micromass, UK; Lohmann et al., 2013). Analyses of alkyl phosphates and polycyclic musks were 179 
performed using GC 6890 (Agilent) coupled to MSD 5975 mass spectrometer (Agilent). For more details 180 
see SI 1.2. 181 
Currently used pesticides (CUPs) were separated using Agilent 1290 series HPLC (Agilent) and detected 182 
with mass spectrometer AB Sciex Qtrap 5500 (AB Sciex, Canada; Brumovský et al., 2016).  183 
Steroid analysis was performed by liquid chromatography (HPLC Agilent 1200 Series) with mass 184 
spectrometry (MS-MS Agilent 6410 Triple Quad) after precolumn derivatization with dansyl chloride 185 
as described previously (Lin et al., 2007; Sadílek et al., 2016).  186 
For the detection of flavonoids and phytosterols, the HPLC-MS/MS method previously described by 187 
Bláhová et al. (2016) was employed.  188 
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Pharmaceuticals were analyzed using a triple stage quadrupole MS/MS TSQ Quantum Ultra mass 189 
spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) coupled with an Accela 1250 LC pump 190 
(Thermo Fisher Scientific) and an HTS XT-CTC autosampler (CTC Analytics AG, Switzerland) as described 191 
previously by Grabic et al., (2012). 192 
LDPE extracts were analyzed for PAHs, PCBs, and HCB according to Allan et al. (2013). For further 193 
details on chemical analyses see SI 1.2. 194 
 195 
2.3. Bioanalysis 196 
Specific toxic potentials were assessed using a battery of bioassays (Table 1). A detailed description of 197 
the bioassays can be found in SI 1.3.1 and Neale et al. (2015a). The sample concentrations in bioassays 198 
were expressed as relative enrichment factor (REF), which expresses the water sample enrichment by 199 
passive sampling and sample processing together with the dilution in the bioassays. The effect in the 200 
sample was expressed as either the concentration causing 20% effect (EC20), the concentration causing 201 
20% inhibition (IC20), or the effect concentration causing an induction ratio (IR) of 1.5 (ECIR1.5) (Table 1). 202 
Log-logistic dose-response and linear regression models were used for the calculation of EC20 and 203 
ECIR1.5, respectively. Cell viability was assessed in parallel and cytotoxic sample concentrations were 204 
excluded from further calculations.  205 
 206 
2.4. Data analysis  207 
2.4.1. Estimation of water volume extracted by passive samplers 208 
The calculated concentrations of chemicals in water (Cw) derived from the passive sampling correspond 209 
to the freely dissolved concentration Cfree (Mayer et al., 2003). Sampling rate RS,SR of individual 210 
compounds to SR passive samplers was modeled as a function of the molar mass M by the water 211 
boundary layer-controlled uptake model from Rusina et al. (2010): 212 
Rs,SR = AB × M-0.47           Equation 1 213 
with an exposure-specific parameter AB. The parameter was estimated from the dissipation of PRCs 214 
from samplers during exposure using a nonlinear least squares method by Booij and Smedes (2010), 215 
considering the fractions of individual PRCs that are retained in the sampler after exposure as a 216 
continuous function of their sampler-water partition coefficient KSR,w. The models applied for SR 217 
samplers are described in detail in Vrana et al. (submitted). 218 
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Cw of individual compounds were calculated from the mass absorbed by the SR samplers NSR, the 219 
degree of equilibrium DEQ that the compound attained during sampler exposure, the mass of sampler 220 
mSR and their sampler-water partition coefficients KSR,w as described in Booij et al. (2007).  221 
DEQmK
N
C SR
SRwSR,
w =         Equation 2       222 
The DEQ was calculated as: 223 
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Since the compounds that caused effects detected in passive sampler extracts were unknown they 225 
were expressed as BEQ per sampler (BEQSR,ED ). A conversion to concentration in water (BEQw) was 226 
approximated using a sampling rate RS,SR of a compound with an intermediate molar mass of 300 g.mol-227 
1, assuming a fully integrative sampling during the entire sampler exposure. In such situations, when 228 
DEQ is <<1, Equation 3 can be simplified to DEQ = RS,SR t/(KSR,w×mSR) and  229 
tR
N
C
SRS
SR
,
w =           Equation 4 230 
The BEQw for SR was calculated as: 231 
tAB
BEQ
tR
BEQ
BEQ SR
SRS
SR
0.47-
,
w
300 
==        Equation 5  232 
For ED samplers, the PRC approach was not applied since its application in adsorption-based samplers 233 
is questionable. The sampling rates of ED samplers were derived from a correlation of uptake of PAHs 234 
and 4-nonylphenol to ED and SR samplers as is described in detail in SI 1.3 and Vrana et al. (submitted). 235 
Sampling rate values of the ED samplers RS,ED were estimated from sampling rates derived for SR 236 
samplers (RS,SR), the calculated overall median FED/SR factor for 10 PAH individuals and 4-nonylphenol, 237 
and the surface areas of both samplers AED, ASR as has been explained in detail by Vrana et al. 238 
(submitted):  239 
   Equation 6 240 
The BEQw for ED was then calculated as: 241 
SRSSRSSRS
SR
ED
SREDEDS RRR
A
A
FR ,,,/, 366.0
392
173
83.0 ===
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BEQw =  
𝐵𝐸𝑄𝐸𝐷
𝑅𝑆,𝐸𝐷𝑡
=
𝐵𝐸𝑄𝐸𝐷
0.366 × 𝑅𝑆,𝑆𝑅𝑡
        Equation 7 242 
 243 
2.4.1. Bioanalytical Equivalent Concentration  244 
The EC and IC values from the different bioassays (Table 1) were converted to BEQbio using Equation 6, 245 
with the EC20 or ECIR1.5 value of the reference compound (rc) and the matching EC20 or ECIR1.5 value of 246 
the extract. 247 
BEQbio= 
EC20 (rc) 
EC20 (extract)
or 
IC20 (rc) 
IC20 (extract)
or
ECIR1.5 (rc) 
ECIR1.5 (extract)
    Equation 8 248 
 249 
To calculate BEQchem, relative effect potency (REPi) of the detected chemicals was calculated from 250 
measured data, complemented by information from the literature or calculated based on data from 251 
the US EPA ToxCast database (US EPA, 2015; Tab. S5). REPi was calculated using Equation 10, with EC10, 252 
IC20 or ECIR1.5 value of the reference compound and the matching EC10, IC20 or ECIR1.5 value of detected 253 
chemical i. REPs derived from the literature data and ToxCast database were based on EC levels 254 
indicated in Tab. S5. Limit of quantification (LOQ) was calculated using equation 6; the extract effective 255 
concentration was replaced by the highest non-cytotoxic sample concentration tested. 256 
REPi= 
EC10 (rc) 
EC10 (i)
 or 
IC20(rc) 
IC20 (i)
or 
ECIR1.5 (rc) 
ECIR1.5 (i)
      Equation 9 257 
BEQchem was calculated from REP and the estimated concentration of each chemical in water in molar 258 
units (cw,i) using Equation 10. 259 
BEQchem= ∑ REPi∙Ci
n
i=1        Equation 10 260 
3. Results and Discussion 261 
3.1. Passive sampling 262 
The Danube river watershed covers a significant part of the European continent reaching into the 263 
territory of nineteen countries of different developmental stages. The river is affected by a range of 264 
pollution sources discharging a wide spectrum of contaminants. On the other hand, being a large river, 265 
the Danube has a great dilution capacity and so the pollutant concentrations in the water may be 266 
relatively low compared to some rivers with a smaller dilution capacity (Keller et al., 2014). To 267 
representatively characterize the river pollution, the current study employed mobile passive sampling 268 
during the cruise of the expedition ship along defined stretches of the Danube. The overall sampled 269 
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river section covered by eight mobile-sampled river stretches spanned through nine countries (Fig. 1). 270 
Employment of two sampler types enabled sampling of chemicals with a wide range of physical-271 
chemical properties. Partitioning-based silicon rubber (SR) samplers have been shown previously to 272 
effectively sorb non-polar chemicals (Rusina et al., 2010; Smedes and Booij, 2012). In order to facilitate 273 
the collection of more polar chemicals, we employed Empore™ SDB-RPS disc adsorption samplers (ED). 274 
The modification of poly(styrene-divinylbenzene) copolymer with sulfonic acid groups in ED was 275 
selected because it provides improved sorption capacity for polar chemicals with lower log Kow such as 276 
pharmaceuticals and their metabolites, steroids, pesticides and their metabolites, explosives, or 277 
amine-containing analytes (Vrana et al., submitted).   278 
Since the uptake principle is identical in both DPS and classical passive sampling, results may be 279 
evaluated using available passive sampler calibration parameters and models. The sampling rates for 280 
SR were determined using dissipation of PRCs from the samplers during their exposure, while for the 281 
ED samplers, the sampling rates were estimated from the relation of surface specific uptake of PAHs 282 
and 4-nonylphenol between SR and ED. The good correlation for these chemicals, which were 283 
integratively accumulated in SR, provided evidence that sampling rates under water-boundary layer 284 
control in ED are proportional to the sampling rates of SR. The proportionality factor of sampling rates 285 
is roughly given by the ratio of surface areas of the two samplers (details in SI 1.3; Fig. S1; Vrana et al., 286 
submitted).  287 
The increase of the sampling rate achieved by means of DPS was significant: in comparison with data 288 
from the passive samplers with the same dimensions subjected to stationary exposure without forced 289 
water exchange, DPS sampling was approximately five times faster (Vrana et al., submitted). This 290 
allowed us to collect and detect many chemicals with concentrations in the pg/L range during less than 291 
two days of sampler exposure (Tab. S2).  292 
The LDPE samplers were used for checking whether the sampled water volume for the DPS device 293 
dedicated to toxicological analyses was equal to the device intended for chemical analysis. PRC release 294 
was monitored for LDPE samplers in both DPS devices per location since they had the same 295 
configuration and were exposed side by side. The comparison was relevant for the situations where 296 
the released PRC fraction fPRC was quantifiable or lower than 80 % (Fig. S2; i.e. d10-FLT and d12-CHR). 297 
Their sampling rate ratio was 1.00±0.11 and 0.93±0.14, respectively, as average across the eight 298 
sampling stretches. The corresponding sampling rates obtained demonstrate that the sampling 299 
performance of the two DPS devices deployed in parallel was equivalent. PRCs were not spiked to SR 300 
and ED samplers for toxicological analysis, but based on the equivalence of LDPE sampling rates in the 301 
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two devices, sampling rates in SR samplers for chemical analysis can be applied as a good estimate of 302 
sampling rates in SR samplers applied for toxicological analysis (details in SI 1.3.3, Fig. S2). 303 
 304 
3.2. Chemical analysis 305 
 From a total of 267 analyzed chemicals, 209 were detected at least in one sample. A number of 306 
detected chemicals ranged from 52 to 70 and 103 to 131 for the SR and ED samplers across stretches, 307 
respectively (Fig. 2). Among non-polar compounds analyzed in the SR samples, triisobutylphosphate, 308 
4-nonylphenol, naphthalene and phenanthrene, and synthetic musk galaxolide were estimated to be 309 
present in the highest free dissolved concentrations in the river water (4-101 ng L-1; Tab. S2). Among 310 
compounds analyzed in the ED samples, the chemicals with the highest estimated concentration in 311 
river water were the pharmaceuticals carbamazepine, irbesartan, and sulphapyridine; atrazine, 312 
bisphenol A, cholesterol and sitosterol (7-17 ng L-1; Tab. S3).  313 
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Fig. 2 The sum of freely dissolved molar concentrations of chemicals in water (Cw), estimated from 315 
their amounts analyzed in passive samplers (bar graph) and a number of chemicals detected 316 
in the samples (diamond); SR samples (black bar and blue diamond) and ED samples (white 317 
bar and empty diamond). S1-2 samples from stationary exposure of samplers downstream of 318 
Bratislava (Slovakia); 1-8 samples from a mobile sampling of river stretches.   319 
 320 
3.3. Bioanalysis 321 
In the present study, we employed bioassays for the assessment of xenobiotic metabolism initiation 322 
by the aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR)-mediated effects. AhR-323 
activation has been previously described to induce carcinogenicity, immunotoxicity and indirectly also 324 
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endocrine disruption (Kortenkamp et al., 2012). PXR induces xenobiotic detoxification systems and is 325 
linked, for example, with liver steatosis and is sensitive to a wide range of chemicals (Creusot et al., 326 
2010). The assessment of endocrine disruptive potential focused on the estrogen receptor (ER) and 327 
androgen receptor (AR)-mediated effects. Effects of xenobiotics on ER and AR signaling are relatively 328 
well characterized and they are reported to affect reproduction, development and play a clear role in 329 
carcinogenicity (Janošek et al., 2006; McLachlan, 2016). While activation and inhibition of ER by 330 
chemicals in water samples has been studied intensively, effects of aquatic samples mediated by AR 331 
have obtained less attention (Brack et al., 2007; Leusch et al., 2017). Exposure to xenobiotics often 332 
causes stress to organisms and it leads to activation of rather non-specific adaptive stress responses 333 
to restore homeostasis such as activation of systems dealing with oxidative stress, genotoxicity or 334 
inflammation. Transcription of many detoxification enzymes is coordinately regulated by antioxidant 335 
response elements (ARE) and their activation can serve as a marker of exposure-related oxidative 336 
stress (Reddy, 2008). The p53-mediated response is triggered by DNA damage and it activates repair 337 
mechanisms or apoptosis. It can thus serve as an indicator of genotoxic chemicals (Duerksen-Hughes 338 
et al., 1999). NF-κB-mediated response plays an important role in inflammatory reactions (Simmons et 339 
al., 2009). 340 
Extracts of both SR and ED samplers elicited quantifiable effects in all employed bioassays except for 341 
the assay indicative of the NF-κB response (Table 3; Fig. 3). In the case of p53-mediated response, the 342 
effects were detected only in six ED samplers with higher sampled water volume and even then, they 343 
were very close to the LOQ. 344 
All other biological endpoints were detected across all mobile and stationary samples and both 345 
sampler types. When comparing the BEQbio of mobile sampled stretches across the assessed endpoints, 346 
spatial patterns along the river for some endpoints were revealed. For example, there was an increase 347 
in the AhR-mediated response in the ED sample at stretch 8 in the river delta in Romania (Fig. 3). There 348 
was also an increase in anti-androgenic potential from stretch 5 onward (Serbia, Romania, and 349 
Bulgaria). Similarly, an increased estrogenic potential was observed in stretch 5 (mainly Serbia and 350 
Romania), where also the highest levels of steroid estrogens, alkylphenols and musks were observed 351 
(Table 2, Tab. S4). This may be related to the fact that significant amounts of wastewaters are released 352 
to the Danube directly without treatment in this part of Europe, which leads to increased levels of 353 
chemicals with endocrine disruptive potential.  354 
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Fig. 3 Spatial profiles of biological potentials in Danube river water, derived from passive sampler 356 
data and expressed as BEQbio of a respective reference compound; SR silicone rubber 357 
samples, ED Empore™ disc samples; S1,2 – stationary sampling site; 1-8 sampled river 358 
stretches (mean±SEM).  359 
 360 
EC values for the SR and ED extracts from both stationary samples and sampled stretches are compared 361 
in Fig. 4. On average for each bioassay, the ED sample EC values were 3.5 to 12.3 times lower than the 362 
SR samplers. This indicates that ED samplers were correspondingly more effective in the collection of 363 
bioactive chemicals across all bioassays which detected significantly more biological potential. Thus, 364 
the assessed endpoints were most likely elicited mainly by polar chemicals, for which the uptake 365 
capacity in SR samplers is low. While this is not surprising for chemicals that act as inducers of oxidative 366 
stress, endocrine disruptors or PXR-activators, the AhR-mediated effect has been often attributed to 367 
more hydrophobic compounds, such as polychlorinated dibenzo-p-dioxins and furans or some PCB 368 
congeners and PAHs. However, it has been shown that a considerable part of the AhR-mediated 369 
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activity is elicited by polar chemicals in water and sediment extracts (Jalova et al., 2013; Liu et al., 370 
2014). Anyway, the greatest difference between BEQbio of SR and ED samplers was observed for 371 
estrogenicity where EC values of ED samples were twelve times lower on average. Estrogenicity was 372 
thus the endpoint where non-polar compounds contributed the least to the overall biological potential 373 
of river water.  374 
 375 
Fig. 4 Effective concentration (EC) values of samples from dynamic passive sampling expressed 376 
as relative enrichment factors of the samples (REF). EC20 of PXR, ER, AhR-mediated effects, anti-377 
androgenic effect (aAR) and ECIR1.5 of ARE and p53-mediated effects; S1-2 samples from 378 
stationary exposure of the samplers downstream of Bratislava (Slovakia); 1-8 samples from a 379 
mobile sampling of river stretches; SR silicone rubber sampler, ED Empore™ disc sampler. 380 
 381 
BEQbio values detected at samples collected during stationary exposure of the DPS device in a sampling 382 
site, which was located at the interface of the mobile sampled stretches 1 and 2, were among the 383 
lowest observed values in the study for all assessed endpoints in the case of ED (Fig. 3). Even when 384 
comparing data from stationary sampling site and stretch 1, which was directly upstream, the BEQbio 385 
values of the ED sample were lower for the stationary samples. This might indicate that mobile 386 
sampling along the river stretches was more effective at sampling bioactive chemicals. On the other 387 
hand, sampling at the stationary site took more than twice as long as in the mobile sampling and it is 388 
possible that due to the longer exposure time at least some of bioactive chemicals reached equilibrium 389 
between the ED samplers and sampled water. Thus, the calculated sampled water volume would be 390 
overestimated for such chemicals and so the BEQbio could be underestimated in the stationary 391 
exposure samples. On the other hand, due to the longer sampling period, some non-polar chemicals 392 
such as benzo(k)fluoranthene, benzo(ghi)perylene or some brominated diphenyl ethers, whose 393 
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concentrations were below method LOQ in samples from the mobile sampling, were quantified in the 394 
stationary sampling site (Tab. S2, S3).  395 
The AhR-mediated BEQbio levels in the samples were 3.8 –14.6 and 11.5–60.1 pg L-1 for SR and ED, 396 
respectively (Table 3). For this endpoint, van der Oost et al. (2017) has proposed an effect-based trigger 397 
value (EBT; i.e. the BEQbio level with a potential ecological health risk, of 150 ng L-1 of benzo(a)pyrene 398 
equivalent). When transformed to the corresponding data format using the REP value of 399 
benzo(a)pyrene (Tab. S5), our data are relatively close to the proposed EBT limit and even exceed the 400 
value in ED sample from the stretch 8 (20–76 and 60–300 ng L-1 of benzo(a)pyrene -equivalent for SR 401 
and ED, respectively).    402 
The observed estrogenicity BEQbio ranged 2–15 and 44–320 pg L-1 in SR and ED samples, respectively. 403 
The concentrations in ED are relatively close to an annual average environmental quality standard of 404 
400 pg L-1 for 17β-estradiol proposed by the European Commission (European Comission, 2015) as well 405 
as the previously proposed EBT values (Jarošová et al., 2014; van der Oost et al., 2017). Jarošová et al., 406 
who derived a safe BEQbio level for water burdened by wastewater treatment plants effluents using in 407 
vivo estrogenic PNECs, proposed the long-time exposure EBT of 200 pg L-1 specifically for the MELN 408 
bioassay employed in the current study. Van der Oost et al. (2017) derived an EBT of 500 pg L-1 BEQbio 409 
from LOEC values for the ER CALUX bioassay. Thus, our results show that estrogenic activity in the 410 
Danube river did not exceed the proposed EBT values, with the exception of stretch 5 in the case of 411 
the BEQ value proposed by Jarošová et al. (2014). On the other hand, even the Danube with its great 412 
dilution capacity contains estrogenic BEQbio levels that are close to or, in case of stretch 5 (Romania, 413 
Serbia), exceed proposed EBT values.  414 
The AR-mediated effect was assessed both in agonistic and antagonistic mode (see SI 1.4), but no 415 
androgenic effects were detected (data not shown) by passive nor large volume solid-phase extraction 416 
(LVSPE) sampling during JDS3 (Liska et al., 2015). In fact, androgenic effects in surface water were 417 
described to be associated with wastewater effluents, while anti-androgenic effects mostly prevail in 418 
the less-impacted surface waters (Jalova et al., 2013; König et al., 2016; Neale et al., 2017b). 419 
Antiandrogenic flutamide BEQbio was 63 –432 and 132–2,707 ng L-1 for SR and ED samples, respectively. 420 
Proposed EBT value for anti-androgenicity based on the AR CALUX assay is 25,000 ng L-1 (van der Oost 421 
et al., 2017), so the detected levels should be safely below the EBT value, even though there might be 422 
some difference in sensitivity between the assay used for the EBT value estimation and MDA-kb2 assay 423 
employed in the present study. 424 
 425 
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3.3.1. Comparison of BEQbio from passive and active sampling 426 
Besides passive sampling by DPS, the LVSPE approach for spot sampling was employed during the JDS3 427 
expedition cruise on the Danube River (Fig. S3; Neale et al., 2015a). In this method, suspended particles 428 
were first removed by flow-through centrifugation before extraction of water and so, similarly to 429 
passive sampling, the active sampling method collected mainly the dissolved fraction of chemicals that 430 
can serve as an estimate of Cfree for chemicals with log Kow lower than five (Prokeš et al., 2012). The 431 
LVSPE samples were assessed using a similar bioassay battery as in the current study. Thus, it was 432 
possible to compare BEQbio of samples obtained by both sampling methods. Nevertheless, DPS samples 433 
reflect pollutants integrated along river stretches, while LVSPE was based on spot sampling, which did 434 
not representatively cover the stretches, thus individual samples could not be compared side by side. 435 
Therefore, it was only possible to compare the two sampling approaches using aggregated data from 436 
both studies. According to this comparison, the determined endocrine-disruptive and xenobiotic 437 
metabolism initiating potential of mixtures of compounds from passive sampling corresponded very 438 
well with LVSPE data considering the difference in sampling approaches (Fig. 5). The comparison of 439 
data from passive and active LVSPE sampling independently confirm that the calculation of sampled 440 
water volume by passive samplers was sufficiently accurate and representative to characterize the 441 
toxic potential of most bioactive chemicals contributing to these effects. Overall, BEQbio of samples 442 
from LVSPE correspond much better with ED samplers than SR samples. It is not surprising since the 443 
SR sampler is designed mainly for non-polar chemicals, and the assessed biological endpoints are 444 
triggered rather by polar chemicals. On the other hand, non-polar chemicals tend to bioaccumulate, 445 
which can increase their potential to elicit chronic toxic effects in organisms in situ. Anyway, for active 446 
LVSPE and passive ED sampling, the ranges and medians of the BEQbio for estrogenic and PXR-mediated 447 
potentials were in very good agreement and so both sampling methods seem to be similarly efficient 448 
for sampling of chemicals with these modes of action. AhR-mediated potential in SR samples 449 
corresponded very well to LVSPE samples, while it was on average more than two times higher in ED 450 
samples. No such effect was observed for the other endpoints that are more sensitive to polar 451 
chemicals.  452 
ARE-mediated oxidative stress potential was on average three-times lower in the ED samples 453 
compared to LVSPE. The difference can be at least partly caused by the fact that LVSPE sample extracts 454 
were assessed for ARE-mediated potential using ARE-bla bioassay, which has differing sensitivity 455 
compared to the AREc32 assay employed in the current study (Stalter et al., 2016). Another adaptive 456 
stress response bioassay detected the p53-mediated effect in six out of ten ED samples with 457 
significantly higher ECIR1.5 than in the LVSPE samples (median ECIR1.5 of 609 and 173 REF, respectively), 458 
while no response was detected for the SR extracts. Thus, neither ED nor SR were effective samplers 459 
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for chemicals affecting the p53 activity. The NF-kB bioassay detected quantifiable effects only in LVSPE 460 
samples, but not in the passive samples. While the LVSPE water samples needed relatively low pre-461 
concentration to elicit quantifiable effect, the passive samples were without any effect even at much 462 
higher pre-concentration levels. The low ARE and p53-mediated potentials and non-quantifiable NFκB-463 
associated effects in the ED extracts indicate the differences in the spectrum of sampled chemicals 464 
between passive and LVSPE sampling. Apparently, the applied passive samplers are less suitable for 465 
sampling compounds causing adaptive stress responses. For LVSPE sampling, a combination of several 466 
adsorbents was used to quantitatively retain compounds with a very broad range of polarity, as well 467 
as neutral and charged chemicals (Neale et al., 2015a). In contrast, EDs consisted of the SDB-RPS 468 
sorbent material that retains mainly hydrophobic compounds, non-ionized polar compounds and 469 
organic cations. Since the SDB-RPS phase contains sulfonic acid functional groups, secondary sorption 470 
interactions can occur especially with basic compounds that contain amine functional groups. On the 471 
other hand, this sorbent is known to have a limited capacity for anionic compounds or dissociating 472 
compounds present dominantly in anionic form (Kaserzon et al., 2014) at neutral or slightly alkaline pH 473 
such as in the Danube river. The compounds with a low uptake capacity from neutral water include 474 
acidic compounds, such as most carboxylic acids (e.g. acidic herbicides or pharmaceuticals, but also 475 
naturally occurring carboxylic acids), some phenols, sulfinic and sulfonic acids and anions in general.  476 
 477 
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Fig. 5 Comparison of bioanalytical equivalent concentrations in river water (BEQbio) calculated 479 
from passive and active sampling throughout all sampling sites and stretches; LVSPE active 480 
sampling (large volume solid phase extraction), SR silicone rubber passive samplers, ED 481 
Empore™ discs passive samplers; n.d.- not detected; data on active sampling taken from Neale 482 
et al. (2015a); the box in the graph consists of two quartiles divided by median, the ends of the 483 
whiskers represent the 10th and the 90th percentile and the dots individual outliers. 484 
 485 
3.3.2. Contribution of detected chemicals to the biological potentials  486 
To compare data from chemical and biological analyses, levels of detected chemicals were converted 487 
to BEQchem using the concentration addition concept. We used REP values either from our own 488 
experiments, from the peer reviewed literature, or the ToxCast database (Tab. S5). For some 489 
chemicals, we were not able to find REP values assessed with the same bioassay as in the current study. 490 
In these cases, use of REP values from an alternative analogous bioassay is indicated in Tab. S5 together 491 
with EC values that were applied for REP calculation because these values differed among literature 492 
sources.  493 
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Unfortunately, information on toxicological properties of many of the detected chemicals and their 494 
bioactivity in the studied endpoints is not available (Fig. S4), which limited the assessment of their 495 
potential contribution to the overall biological response. As soon as possible, the most widespread and 496 
abundant pollutants need to be prioritized for the characterization of their bioactivities to improve the 497 
mass-balance calculations and explanation of the observed effects. 498 
Between 0.7 to 7.9 and 0.3 to 2% of BEQbio for SR and ED samples, respectively, was explained by 499 
detected chemicals for the AhR-mediated response (Table 3). The main portion of BEQchem was 500 
contributed by PAHs (namely benzo(k)fluoranthene, benzo(b)fluoranthene, benzo(j)fluoranthene and 501 
chrysene) in the SR samples and benzo(k)fluoranthene, terbuthylazine, propiconazole and 4-502 
nonylphenol in ED (Fig. 6). A higher portion of the BEQbio was explained in samples from the stationary 503 
exposure because of benzo(k)fluoranthene, whose concentration was below LOQ in the samples from 504 
the mobile sampling. The detection of this chemical in the stationary samples is likely caused by the 505 
longer integrative sampling at the stationary site which allowed sampling of its quantifiable level.  506 
Less than 0.2% of PXR-mediated BEQbio was explained in the SR samples, with 4-nonylphenol as the 507 
main contributor (Fig. S5). In the ED samples, less than 0.4% of the BEQbio was explained, with 4-t-508 
octylphenol, estrone, clotrimazole and metolachlor the main contributors of toxicity. Neale et al. 509 
(2015a) observed a similar level of explicability with samples from the parallel active sampling and also 510 
identified metolachlor as the main driver. Thus, either the more significant PXR activators were not 511 
identified yet or PXR is not very specific and it is activated by a large number of weak agonists. It might 512 
be also possible that synergistic interaction plays a role in the low explicability of this endpoint because 513 
it has been described that the ligand-binding domain of PXR can accommodate more than one weak 514 
agonist at the same time (Delfosse et al., 2015). 515 
While estrogenic BEQbio was explained by 0.2–3 % with bisphenol A, 4-nonylphenol, and 4-t-516 
octylphenol as significant contributors in SR, 25 to 104% of estrogenicity was explained in the ED with 517 
estrone, 17β-estradiol and estriol, which showed very limited accumulation in SR (unpublished data). 518 
Other chemicals played a minor role. This supports the importance of steroids as water contaminants 519 
that play the most significant role in estrogenicity of waste and surface waters (Miège et al., 2009). 520 
Anti-androgenicity was explained mostly by less than 4% and 6% in the SR and ED sampler extracts, 521 
respectively. The main contributors were tris(1,3-Dichloro-2-propyl)phosphate, bisphenol A, 4-t-522 
octylphenol and 4-nonylphenol in SR extracts. The main identified contributors in ED extracts were 523 
clotrimazole, 4-t-octylphenol and ketoconazole. The rest of 19 identified anti-androgens did not 524 
contribute significantly.  525 
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ARE-mediated oxidative stress BEQbio was explained by less than 0.3 % with benzo(b)fluoranthene, 4-526 
nonylphenol and benzo(a)pyrene in SR. In ED samples, less than 0.05 % of the BEQbio was explained 527 
and the main contributors were bisphenol A, 4-nonylphenol, propiconazole and atrazine in case of 528 
extracts from mobile sampling together with benzo(b)fluoranthene and benzo(a)pyrene in case of 529 
samples from stationary exposures. Similarly limited fraction of oxidative stress-mediated effects 530 
explained by detected chemicals was reported in the parallel active sampling study using an analogous 531 
ARE-bla bioassay (Neale et al., 2015a). Nevertheless, oxidative stress is probably elicited by a large 532 
number of diverse chemicals so it is not likely that there would be only a few drivers of this effect 533 
explaining a considerable portion of the BEQbio in most environmental chemical mixtures. While p53-534 
response was below LOQ in SR samples and it was quantified in six of ten ED samples (Table 3), the 535 
detected chemicals allowed calculation of BEQchem (Fig. S6). The calculated BEQchem levels were lower 536 
than 0.004 and 0.015 ng L-1 for SR and ED samplers, respectively, which was below LOQ of the bioassay 537 
(median value 31 and 59 ng L-1, respectively). BEQchem explained less than 0.02% of the BEQbio levels in 538 
the ED samples with the quantifiable response. This was comparable with data from LVSPE sampling 539 
where BEQchem explained 0.004 – 0.07 % of BEQbio (Neale et al., 2015a).  540 
Our data document that employed passive sampling worked well for capturing chemicals responsible 541 
for the common studied endpoints such as AhR-, ER and AR-mediated activity, which are known to be 542 
associated with numerous known pollutants. On the other hand, in case of adaptive stress endpoints, 543 
namely p53- and NF-kB-mediated response, the effectiveness of the passive sampling was lower 544 
compared to the LVSPE sampling. Nevertheless, the drivers of these responses in surface waters are 545 
mostly unknown. For example, none of the 272 analyzed compounds in LVSPE samples were known to 546 
induce NF-kB according to the ToxCast database (Neale et al., 2015a). This was also documented by 547 
the low explicability of the observed BEQbio by the detected chemicals in case of p53-mediated 548 
genotoxic potential and ARE-mediated response despite the relatively large number of chemicals that 549 
were taken into account. Considering the selectivity of the used ED sampler, the chemicals present in 550 
water in an anionic form could contribute to the effects selectively detected in LVSPE samples. To 551 
better capture these types of chemicals, it is possible to broaden the applicability range of Empore™ 552 
disk-based passive samplers to increase their capacity for binding anionic compounds. There is a 553 
variant of Empore™ disk, Empore™ Anion-SR available that is, similar to SDB-RPS, also based on 554 
polystyrene divinylbenzene particles, but contains additional strong anion exchange (SAX) functional 555 
groups. This disk variant was specifically designed for the extraction of acidic compounds (e.g., 556 
carboxylic acids) from water samples. For sampling even broader range of compounds, including the 557 
dissociating acids and bases, SDB-RPS and Anion-SR Empore™ disks could be exposed side by side and 558 
their extracts combined to make a composite sample.  559 
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Fig. 6 Percentage of the bioanalytical equivalents (BEQbio) of ER and AhR- mediated effects 562 
explained by the detected chemicals (BEQchem) in samples from a dynamic passive sampling 563 
of the Danube river; data from other bioassays are in Fig. S5 and S6; SR silicone rubber 564 
samples, ED Empore™ discs samples; S1,2 – stationary sampling site; 1-8 sampled river 565 
stretches.  566 
 567 
4. Conclusions 568 
The DPS system provided a representative picture of the pollution situation at the studied site and 569 
along the defined river stretches. The system could thus be suitable for sampling of transects of large 570 
water bodies including rivers, lakes or seas. DPS device has effectively increased the sampling rate of 571 
the passive samplers and this approach allowed toxicological profiling and detection of many chemicals 572 
present in the water down to pg L-1 range in a short sampling time of several days. An integrated 573 
approach combining passive sampling with chemical and biological analyses was shown suitable for 574 
spatial profiling of a relatively less polluted river. Our data show that passive sampling should not be 575 
limited to only one type of sampler. The complementarity of the samplers for hydrophilic and 576 
hydrophobic compounds has been clearly demonstrated. While the data from bioanalysis, which 577 
provides information on the sampled pollutant mixtures, indicated that most of the detected biological 578 
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effects were elicited by hydrophilic chemicals, the hydrophobic compounds have a higher 579 
bioaccumulative potential that could increase their relevancy for chronic impact on the exposed river 580 
ecosystem. However, besides estrogenicity only small portion of the biological effects could be 581 
explained by analyzed chemicals. This finding is also influenced by the lack of data on the biological 582 
potencies of detected chemicals. Comparison of the data from passive and active sampling indicates 583 
that the sampling rate of passive samplers for compounds contributing to endocrine-disruptive and 584 
xenobiotic metabolism potential can be relatively accurately estimated and confirms that both 585 
sampling approaches provide efficient means to monitor these chemicals. While LVSPE provides site-586 
specific information, DPS enables integrative characterization of the pollution situation over space and 587 
time depending on the design of its employment. 588 
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Table 1 Overview of bioassays in the study 
Bioassay Endpoint Positive reference compound Method reference Data evaluation method 
EC  
value 
CAFLUX-H4G1.1c2 Activation of AhR 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (Nagy et al., 2002) Log-logistic dose-response model EC20 
MDA-kb2 Activation / Inhibition of AR Dihydrotestosterone / Flutamide (Wilson et al., 2002) Log-logistic dose-response model IC20 
HG5LN-hPXR Activation of PXR SR 128131 (Lemaire et al., 2006) Log-logistic dose-response model EC20 
MELN Activation of ER 17β-Estradiol (Balaguer et al., 1999) Log-logistic dose-response model EC20 
AREc32 Oxidative stress response tert-Butylhydroquinone (tBHQ) 
(Escher et al., 2012; Wang et 
al., 2006) 
Linear concentration-effect curve ECIR1.5 
p53RE-bla p53 response Mitomycin (Neale et al., 2015b) Linear concentration-effect curve ECIR1.5 
NF-κB-bla NF-κB response Tumor necrosis factor alpha (TNFα) (Jin et al., 2015)  Linear concentration-effect curve ECIR1.5 
1Tetraethyl 2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethenyl-1,1-bisphosphonate 
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Table 2 Sum concentrations (pg L-1) of groups of chemicals detected in samples from dynamic passive sampling; 1-8 samples from mobile sampling of river stretches; 
SR silicone rubber sampler, ED Empore™ disc sampler; No. number of analyzed chemicals in the category; <LOD concentrations below the limit of detection; for molar 
concentrations or individual chemical levels see SI; CUPs-current use pesticides, PAHs- polycyclic aromatic hydrocarbons, PCBs- polychlorinated biphenyls, OCPs- 
organochlorinated pesticides, BDEs- brominated diphenyl ethers, NBFRs- novel brominated flame retardants  
Sampler Chemicals  No. S1 S2 1 2 3 4 5 6 7 8 
ED ATBs 31 12,670 12,230 11,476 23,922 23,126 17,393 21,699 12,656 33,195 29,262 
 
Cardiovascular 15 14,183 14,964 11,748 19,693 21,649 11,367 11,730 7,262 10,764 11,026 
 
Psychoactive 30 25,439 21,421 17,860 28,957 26,290 18,019 24,001 24,855 33,596 28,750 
 
Antihistamins 8 255 91 275 <LOD 112 348 242 <LOD 583 <LOD 
 
Antifungals 8 3,260 4,898 4,121 8,291 8,146 8,476 10,560 10,466 10,582 9,297 
 
Antidiabetics 4 31 4 32 42 98 35 20 21 97 27 
 
Statins 4 289 318 286 400 1,259 1,031 1,219 418 590 507 
 
Other pharm.1 8 290 248 <LOD <LOD 122 533 <LOD 295 <LOD <LOD 
 
CUPs 40 17,543 28,746 33,152 20,492 32,509 17,067 27,033 28,373 67,140 41,961 
 
Alkylphenols 3 7,630 7,790 12,225 12,484 15,209 26,311 34,513 20,982 22,399 19,817 
 
PAHs 29 6,274 7,541 9,633 12,134 22,411 17,384 8,111 8,007 6,981 12,382 
 
Steroids 5 176 198 201 351 582 626 1,151 398 770 816 
 
Phytosterols 11 72,010 52,776 29,885 45,964 49,994 34,753 47,458 46,209 48,996 50,809 
  Flavonoids 8 798 955 954 636 806 2,916 1,990 693 3,211 10,329 
             
SR PAHs 29 17,342 23,000 18,215 21,063 51,067 37,296 15,975 12,002 13,965 20,704 
 
PCBs 7 217 244 171 291 167 172 369 158 307 295 
 
OCPs 12 188 223 156 244 372 313 358 465 808 1,872 
 
BDEs 9 4 6 22 2 <LOD <LOD <LOD <LOD <LOD <LOD 
 
NBFRs 15 7 13 23 25 15 9 17 22 5 12 
 
Musks 6 18,582 27,839 11,240 11,894 18,317 17,915 25,395 10,060 13,471 9,732 
  Alkylphenols 3 2,932 3,526 5,749 6,270 7,959 10,012 8,511 3,525 7,278 6,236 
 Alkylphosphates 14 186,725 213,440 98,815 121,763 111,142 79,046 104,446 147,234 139,681 148,697 
1 furosemide, alfuzosin, naloxone, ranitidine 
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Table 3 Toxic potentials of samples assessed with bioassays expressed as bioanalytical equivalents of respective reference compound (BEQbio ± SD) and bioanalytical 
equivalents predicted from chemical analyses (BEQchem) with percent of BEQbio explained by chemical analyses in brackets. AhR – aryl hydrocarbon receptor–mediated 
response (tetrachlorodibenzo-p-dioxin); ER – estrogenicity (17β–estradiol); anti-AR – antiandrogenicity (flutamide); PXR – pregnane X receptor-mediated response 
(SR12813). 
 
 
 sample 
No. S1 S2 1 2 3 4 5 6 7 8 
endpoint sample 
 
Static 
exposure 1 
Static 
exposure 2 
Passau–
Bratislava 
Bratislava–
Budapest 
Budapest–
Vukovar 
Vukovar–
Belgrade 
Belgrade–
Turnu-Severin 
Turnu-
Severin–
Ruse Ruse–Braila Braila–Tulcea 
AhR   
[pg L-1] 
SR 
BEQbio 9.7 ± 3.5 3.8 ± 1.1 14.6 ± 5 9.7 ± 3.4 6.6 ± 1.9 7.5 ± 1.5 8.2 ± 2.5 7.2 ± 1.9 7.7 ± 0.8 10.6 ± 3.1 
BEQchem 0.32 (3.3 %) 0.3 (7.9 %) 0.1 (0.7 %) 0.13 (1.3 %) 0.16 (2.4 %) 0.07 (0.9 %) 0.11 (1.4 %) 0.11 (1.6 %) 0.06 (0.8 %) 0.08 (0.7 %) 
ED 
BEQbio  15.5 ± 1 11.5 ± 1.1 23.2 ± 5.4 30.6 ± 10.2 22 ± 4.9 21.4 ± 0.6 12.9 ± 3.9 28.3 ± 7.7 26.7 ± 7.6 60.1 ± 20.4 
BEQchem 0.249 (1.6 %) 0.265 (2.3 %) 0.141 (0.6 %) 0.131 (0.4 %) 0.267 (1.2 %) 0.11 (0.5 %) 0.135 (1 %) 0.107 (0.4 %) 0.195 (0.7 %) 0.163 (0.3 %) 
PXR  
[ng L-1] 
SR 
 BEQbio 211 ± 73 148 ± 103 134 ± 23 83 ± 32 123 ± 48 72 ± 41 104 ± 32 261 ± 108 205 ± 68 206 ± 36 
BEQchem 0.04 (0.02 %) 0.07 (0.05 %) 0.09 (0.07 %) 0.09 (0.11 %) 0.12 (0.09 %) 0.14 (0.2 %) 0.12 (0.11 %) 0.05 (0.02 %) 0.11 (0.05 %) 0.1 (0.05 %) 
ED 
BEQbio 314 ± 206 200 ± 115 685 ± 281 773 ± 292 237 ± 56 1,118 ± 148 644 ± 130 1,613 ± 670 720 ± 318 1,173 ± 207 
BEQchem 0.39 (0.2 %) 0.46 (0.4 %) 0.49 (0.1 %) 0.61 (0.1 %) 0.85 (0.4 %) 0.98 (0.1 %) 1.52 (0.2 %) 0.84 (0.05 %) 1.23 (0.2 %) 1.03 (0.1 %) 
ER  
[pg L-1] 
SR 
BEQbio 3.6 ± 0.2 2.6 ± 0.4 5.7 ± 0.7 2 ± 0.1 10.6 ± 1.9 5.4 ± 0.2 6.8 ± 0.8 11.2 ± 1.5 15.6 ± 2.4 12.6 ± 0.2 
BEQchem 0.12 (3.3 %) 0.12 (4.8 %) 0.08 (1.4 %) 0.08 (3.7 %) 0.13 (1.2 %) 0.15 (2.7 %) 0.11 (1.7 %) 0.03 (0.3 %) 0.08 (0.5 %) 0.09 (0.7 %) 
ED 
BEQbio 44.4 ± 24 49.7 ± 9 83.2 ± 22 155.5 ± 24 163.9 ± 37 140.1 ± 26 320.3 ± 67 86 ± 38 131.4 ± 17 150.6 ± 49 
BEQchem 19.7 (44 %) 22.2 (45 %) 22.6 (27 %) 39 (25 %) 105.3 (64 %) 117.9 (84 %) 228.6 (71 %) 47.4 (55 %) 138.3 (105 %) 144.2 (96 %) 
anti-AR  
[ng L-1] 
SR 
BEQbio 273 ± 84 74 ± 24 274 ± 100 246 ± 51 258 ± 111 63 ± 11 146 ± 33 202 ± 30 194 ± 36 432 ± 36 
BEQchem 1.96 (0.7 %) 3.29 (4.5 %) 1.79 (0.7 %) 1.13 (0.5 %) 1.65 (0.6 %) 1.17 (1.8 %) 1.04 (0.7 %) 0.85 (0.4 %) 1.23 (0.6 %) 1.1 (0.3 %) 
ED 
BEQbio 334 ± 51 132 ± 46 599 ± 189 865 ± 234 592 ± 45 595 ± 148 1,640 ± 542 2,707 ± 289 1,849 ± 531 1,708 ± 495 
BEQchem 
7.29 (2.2 %) 8.38 (6.4 %) 9.33 (1.6 %) 15.25 (1.8 %) 17.79 (3 %) 
16.41 (2.8 
%) 21.29 (1.3 %) 19.42 (0.7 %) 21.48 (1.2 %) 15.23 (0.9 %) 
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ARE  
[ng L-1] 
SR 
BEQbio 327 ± 230 395 ± 262 782 ± 344 962 ± 520 659 ± 288 827 ± 672 647 ± 351 433 ± 289 1,012 ± 623 1,164 ± 787 
BEQchem 
1.324 (0.41 
%) 1.25 (0.32 %) 0.792 (0.1 %) 0.83 (0.09 %) 1.09 (0.17 %) 
0.62 (0.07 
%) 1.15 (0.18 %) 0.7 (0.16 %) 0.51 (0.05 %) 0.58 (0.05 %) 
ED 
BEQbio 1,181 ± 511 1,054 ± 214 2,540 ± 577 2,724 ± 971 2,449 ± 622 2,219 ± 193 1,838 ± 339 1,726 ± 378 2,063 ± 439 2,071 ± 361 
BEQchem 
0.84 (0.07 %) 1.07 (0.1 %) 0.75 (0.03 %) 0.65 (0.02 %) 0.99 (0.04 %) 
0.81 (0.04 
%) 1.06 (0.06 %) 1.3 (0.08 %) 1.93 (0.09 %) 1.96 (0.09 %) 
p53  
[ng L-1] 
SR 
BEQbio <17.5 <16.1 <25.3 <50.9 <30.7 <32 <30.7 <33 <54 <59.6 
BEQchem 0.0016 0.0045 0.0005 0.0005 0.0005 0.0004 0.004 0.0003 0.0003 0.0004 
ED 
BEQbio 50 ± 1 38 ± 5 83 ± 9 <95 102 ± 16 <60 85 ± 10 86 ± 7 <101 <112 
BEQchem 
0.004 (0.008 
%) 
0.005 (0.012 
%) 
0.004 (0.005 
%) 
0.003 
0.005 (0.005 
%) 
0.01 0.014 (0.017 %) 
0.007 (0.008 
%) 
0.008 0.008 
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1 Passive sampling  
 
The DPS devices were deployed on the frontal deck of the expedition ship. For sampling, the device 
was immersed in a flow-through system that consisted of a 600 L stainless steel tank. The river water 
in the tank was exchanged at a rate of approx. 3 m3 h-1 by a high-performance pump. The water intake 
to the chamber was provided by a vertical steel pipe positioned in front of the ship. The water sampling 
depth was approx. 0.5 m below the water level. Two sets of DPS samplers were employed in stationary 
sampling site Čunovo (Slovakia) located at the interface of stretches 1 and 2. 
 
The silicone rubber (SR) sampler consisted of a single sheet of Altesil® silicone rubber with dimensions 
14×28 cm and 0.5 mm thickness. The mass of a sampler was approx. 23 g and the surface area exposed 
to water 392 cm2 (one side of the sheet). Prior to use all SR samplers were Soxhlet-extracted in ethyl 
acetate for 72 h to remove non-polymerized residues. SR samplers for chemical analyses were spiked 
prior to exposure with Performance Reference Compounds (PRCs) that were partially released during 
exposure. The employed PRC mixture contained perdeuterated biphenyl and 13 polychlorinated 
biphenyl (PCB) congeners that do not occur in technical mixtures (PCB 1, PCB 2, PCB 3, PCB 10, PCB 14, 
PCB 21, PCB 30, PCB 50, PCB 55, PCB 78, PCB 104, PCB 145, PCB 204). The residual concentration of 
PRCs was compared with the initial amount of PRCs analyzed in samplers that have not been exposed.  
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The ED sampler consisted of 10 solid phase extraction disks Empore® SDB-RPS with 47 mm diameter. 
The mass of a sampler was approx. 3.2 g and the surface area exposed to water was 173 cm2. Before 
exposure, Empore discs were washed and conditioned by subsequent immersing in 1) 100 ml acetone; 
2) 100 ml isopropanol; 3) 100 ml methanol, 4) 2x 100 ml ultrapure water and kept immersed in 
ultrapure water until exposure. For this sampler type, PRCs were not used. ED sampling rate was 
determined indirectly from SR sampling rate and levels of PAHs and 4-nonylphenol that were detected 
both in SR and ED samples as described in detail in chapter S1.3 and Vrana et al.( submitted). 
 
The sampling was performed only during cruising of the ship or when the ship was anchored outside 
harbors in areas without visible pollution point sources e.g. wastewater discharges, industrial areas 
next to the river or sites with visible oil film on the surface of the water. The sampling device was 
always switched off before entering harbors and resumed upon leaving the harbors. The samplers 
were mounted into the DPS device directly before sampling and recovered immediately after finishing 
the sampling. The recovered samplers were placed back into their respective storage containers, 
stored in a refrigerator at 4°C on board of the ship and transported to the processing laboratory once 
per week, where they were stored in a freezer at -20°C.  
 
1.1 Sample processing 
1.1.1 Silicone rubber (SR) sheets 
 
Before extraction, SR samplers for chemical analyses were spiked with recovery internal standards 
(RIS; d8-naphthalene, d10-phenanthrene, d12-perylene, PCB 4, PCB 29, PCB 185, a mixture of 13C BDEs, 
C13 caffeine, d13-alachlor, d6-diuron, d10-simazine, 4-n-nonylphenol). The SR samplers were extracted 
for 8 hours in methanol using Soxhlet extraction. The volume of the extract was reduced using 
Kuderna-Danish (K-D) apparatus and under nitrogen flow to 2 ml. Extracts of samplers intended for 
bioanalysis were processed in the same way but without spiking any standards. After processing, they 
were split to aliquots for analysis by the different bioassays. 20 % aliquot of the sample for chemical 
analysis was used for instrumental analysis by LC/MS methods. The remaining 80 % aliquot of samples 
for chemical analysis was azeotropically transferred to hexane using K-D apparatus. Aliquots of the 
extract were divided into vials for different types of GC/MS analysis. The extract aliquots for analysis 
of PAHs were further cleaned-up by a silica gel column using diethyl ether/acetone elution. The extract 
aliquots for analysis of organochlorine compounds (OCs), polybrominated diphenyl ethers (PBDEs) and 
PRCs were purified by a clean-up using activated silica gel modified with sulfuric acid. Following clean-
up, addition of internal standards and volume reduction using a K-D apparatus, samples were analyzed 
using a GC-MS/MS method for indicator PCBs, PBDEs, organochlorinated pesticides (OCPs) and PRCs.  
1.1.2 Empore disks 
 
Unlike ED samplers for bioanalysis, the samplers for chemical analysis were spiked with recovery 
internal standards (c13-caffeine, c13-triclosan, m8-PFOA, n8-PFOS, c13-alachlor, d6-diuron, d10-simazine, 
deuterated EE2, n-nonylphenol). All samplers where then freeze-dried for 24 hours in the original 
containers that were used for sample storage and transport. The disks were extracted three times by 
overnight (12 h) slow shaking at room temperature with 70 ml acetone each. The combined extracts 
were reduced by vacuum rotary evaporation to 10 mL. After removal of particles by filtration through 
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a layer of anhydrous Na2SO4 the extract was further reduced in volume to approx. 1 mL. The acetone 
extract was transferred to methanol by addition of methanol (20 mL) and subsequent evaporation and 
a nitrogen flow to further reduce in volume to 2 mL. The extract was split to aliquots for different types 
of analysis.  
1.1.3 Low-density polyethylene (LDPE) sheets 
 
 LDPE samplers from both parallel DPS sampling devices were extracted twice by soaking overnight 
with n-pentane (100 mL). Recovery standards (for PAHs, PCBs and OCPs) were added to the extraction 
jar during the first extraction. Recovery standards were d8-naphthalene; d10-biphenyl; d8-
acenaphthene; d10-dibenzothiophene, d10-pyrene, d12-benz[a]anthracene, d12-perylene, PCB 30, 
PCB 53, and PCB 204. The sample volume was reduced to 2 mL by a gentle stream of nitrogen at room 
temperature. Extracts were first split into two equal fractions by volume. One fraction was stored as a 
reserve and the other received a general clean-up using gel permeation chromatography (GPC). This 
post-GPC sample was again split into two equal fractions by volume; the first of these was reduced in 
volume using nitrogen and analyzed for PAHs; the second received treatment with 2×1 mL 
concentrated sulfuric acid, was reduced in volume and analyzed for PCBs and OCPs. Details of the 
procedure are described in Allan et al. (2013). 
1.2 Chemical analysis 
 
SR sampler extracts were analyzed using GC-MS/MS (GC 7890 / MS-MS Triple Quadrupole 7000B 
(Agilent), equipped with HT8 SGE Analytical Science column for PCB 28, PCB 52, PCB 101, PCB 118, PCB 
153, PCB 138, PCB 180, and OCPs: α-hexachlorocyclohexane (HCH), β-HCH, γ-HCH, δ-HCH, p,p´-DDE, 
p,p´-DDD, o,p´-DDT and p,p´-DDT, hexachlorobenzene (HCB), and pentachlorobenzene (PeCB). 
Polycyclic aromatic hydrocarbons were analyzed using GC 7890 / MS5975 (Agilent) equipped with J&W 
Scientific fused silica DB-5MS column. Detection was performed in single ion monitoring mode, the 
temperature of the ionic source was 320°C and quadrupole temperature 150°C. One μL sample was 
injected in splitless mode at 280°C. Helium (purity 5.5) was used as carrier gas at a flow of 1.5 mL min-
1. The GC instrument was operated with an initial oven temperature of 80°C (1 min hold), then ramped 
at 15°C min-1 to 180°C and at 5°C min-1 to 310°C which was held for 20 min.  
PBDEs were analyzed by GC equipped with 15m × 0.25 mm × 0.10 μm RTX-1614 column (Restek, USA). 
HRMS (AutoSpec Premier) was operated in EI+ mode at the resolution of >10 000. 
SR and ED sampler extracts were analyzed for alkylphenols using dansyl chloride derivatization and LC-
MS/MS detection according to Pernica et al. (2015). 4 -nonylphenol served as an internal standard. 
Chromatographic separation was performed using LC Agilent 1200 Infinity Series, equipped with 
chromatographic column ACE 5 C18, 150 × 4.6 mm i.d., 5 µm particle size (ACE, Scotland, UK). Water 
containing 7 mmol L-1 formic acid (A) and methanol (B) was used as a mobile phase. The isocratic 
elution of 10 % (A) and 90 % (B) was used at a flow rate of 0.5 mL min-1. The Agilent 6410 Triple 
Quadrupole (Agilent Technologies, Santa Clara, CA, USA) was used for MS/MS analysis. The instrument 
was operated in the ESI-positive MRM mode. Two MS/MS transitions were used for analyses. 
Chromatographic analyses of alkyl phosphates and polycyclic musks were performed using GC 6890 
(Agilent, USA) coupled to MSD 5975 mass spectrometer (Agilent, USA) operated in EI+ mode. 
Compounds were separated on the column HP-5MS (30m x 0.25mm x 0.25µm film) in selected ion 
mode (SIM). Helium was used as mobile phase at 1.2 mL min-1 at constant pressure. One or two µL of 
extract were injected in pulsed split-less mode at 280 °C. GC temperature program started at 70 °C 
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(hold for 2 min), ramped 25 °C min-1 to 150 °C (hold for 0 min), ramped 3 °C min-1 to 200 °C (hold for 0 
min), ramped 8 °C min-1 to 280 °C (hold for 10 min).  
 
1.3 Estimation of sampling rates 
 
1.3.1 Silicone rubber samplers 
 
As described in detail in Vrana et al.( submitted), concentrations of chemicals dissolved in water were 
calculated from amounts of analytes accumulated in SR samplers. Amounts of analytes absorbed by 
the samplers follow a first-order rate law to equilibrium. Aqueous concentrations were calculated from 
the mass absorbed by the samplers, the in situ sampling rate (Rs) of the compounds and their sampler-
water partition coefficients (Smedes et al., 2009) as described in Smedes and Booij (2012). Sampling 
rates were estimated from dissipation of PRCs from SR samplers during exposure using nonlinear least 
squares method by Booij and Smedes (2010), considering the fraction of individual PRCs that remained 
in the SR after the exposure as a continuous function of their sampler-water partition coefficient and 
their molecular mass, with adjustable parameter B. Rs for a compound accumulated under water-
boundary layer control was calculated as a function of its molecular mass Rs=B×M-0.47 (Rusina et al., 
2010).  
1.3.2 Empore disc samplers 
 
For ED samplers, calibration is based on levels of 4-nonylphenol and 10 PAHs that were detected in 
both ED and SR samplers throughout all sampled river stretches. Surface specific sampling rates 
appeared to be well correlated and their values were close to equal. The Rs for ED sampler was 
calculated from Rs of SR and their respective sampling areas using equation S1.   
𝑹𝒔 (𝑬𝑫) 
𝑨 (𝑬𝑫)
 =  𝟎. 𝟖𝟑 
𝑹𝒔 (𝑺𝑹) 
𝑨 (𝑺𝑹)
         Equation S1 
 
Thus, the overall ED sampling rate was calculated from SR sampling rate by comparing the levels of 
PAHs and 4-nonylphenol in SR and ED samplers as the median of sampling rates of the individual 
chemicals used for the calibration throughout the river stretches (Fig. S; for more details see Vrana et 
al., submitted).  
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Fig. S1 Comparison of levels of PAHs and 4-nonylphenol per sampling surface of SR and ED 
samplers from 8 mobile and 2 stationary DPS samples.   
 
1.3.3 Mutual comparison of two co-deployed DPS devices 
 
The two co-deployed DPS devices may exhibit some differences if their pumps differed in volume flow 
rate. Their mutual comparison was done using a LDPE stripe mounted into each device during each 
exposure. Sampling performance of the LDPE samplers was assessed by monitoring release of 6 
deuterated PAH PRCs during exposure. Since the exposure time t and mass mx of LDPE stripes deployed 
in both DPS devices was the same (0.71±0.02 g), from Equation S2 the ratio of sampling rates of a PRC 
in both devices is related to the ratio of its retained fractions after exposure: 
)f(
)f(
R
R
CHEM,PRC
TOX,PRC
CHEM,s
TOX,s
ln
ln
=         Equation S2 
 
where the subscripts 'TOX' and 'CHEM' denote the two co-deployed DPS devices containing samplers 
intended for toxicological and chemical analysis, respectively. The comparison is relevant only for PRCs 
for which fPRC was quantifiable and lower than 80 % (Fig. S2). 
Those PRCs included d10-FLT and d12-CHR. d10-ACE, d10-FLU, and d10-PHE were released from the 
samplers to concentrations below their limit of quantification, whereas more than 80 % of d12-BeP 
remained in the samplers. For d10-FLT and d12-CHR the calculated Rs,TOX/Rs,CHEM ratio in the eight 
sampling stretches was 1.00±0.11 and 0.93±0.14, respectively.  
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Fig. S2 Comparison of PRC fractions retained in LDPE sheets in two co-deployed DPS devices 
(TOX PS and CHEM PS) in parallel in 8 Danube stretches 
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1.4 Bioanalysis 
 
AhR-mediated response (CAFLUX) 
This type of toxicity was assessed using the rat hepatoma cell line H4G1.1c2 stably transfected by EGFP 
under control of dioxin response element. The assay was performed as described in Nagy et al. (2002). 
Cells were seeded to black clear-bottom 96 well plate in 100 µL of DMEM supplemented with 10% fetal 
bovine serum (FBS) in density 2 × 105 cells/mL. After 24h incubation at 37°C, dilution series of extracts 
were added in 100 µL of the cultivation medium with DMSO as a solvent (final concentration 0.5% v/v). 
After 24 h incubation, the medium was replaced and fluorescence measured. 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (TCDD) served as the positive reference compound. The data were 
expressed as EC20 using a log-logistic dose-response model. Cytotoxic concentrations of extracts were 
excluded from the calculation based on viability data assessed with neutral red uptake assay 
(Freyberger and Schmuck, 2005). 
PXR-mediated response (HG5LN-hPXR)  
The HG5LN-hPXR assay based on human HeLa cell line served for the assessment of the activation of 
the human pregnane X receptor (PXR) and was performed according to Creusot et al. (2010) with minor 
modifications. Briefly, HG5LN-hPXR cells in DMEM without phenol red supplemented with 5% fetal calf 
serum (FCS) were seeded in a white 96-well plate in 100 µL of cell suspension at a density of 6×105 
cells/mL and incubated for 24 h at 37°C. The sampler extracts diluted in phenol red-free DMEM 
supplemented with 3% dextran-coated charcoal-treated fetal calf serum (DCC-FCS) were added and 
the exposed cells were incubated for a further 16 h. Before luminescence measurement, exposure 
medium was replaced with 50 µL of medium supplemented with 0.3 mM luciferin. SR 12813 (Tetraethyl 
2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethenyl-1,1-bisphosphonate) was used as the positive reference 
compound. The data was expressed as EC20 using a log-logistic dose-response model. 
(Anti-)androgenicity (MDA-kb2) 
Human mammary carcinoma-derived cell line MDA-kb2 was used for the assessment of androgen 
receptor-mediated responses (androgenicity and anti-androgenicity). The cells were grown in 
Leibovitz’s L-15 medium supplemented with 10 % FBS at 37 °C and normal air with high relative 
humidity. The experiment was performed in 96-well plates in L-15 medium supplemented with 10% 
dextran-charcoal-treated FBS. Androgen dihydrotestosterone (DHT) was used as a positive reference 
compound. For the assessment of androgenic effect, the cells were exposed to samples alone. To 
assess the anti-androgenic effect, cells were exposed to extracts in combination with the physiological 
ligand of the AR DHT (0.1 nM). The anti-androgenic effect was quantified using flutamide as model 
anti-androgen. The androgenic and anti-androgenic potential was expressed as EC20 and IC20, 
respectively, using a log-logistic dose-response model. The viability of the cells in the assay was 
evaluated using neutral red uptake assay (Freyberger and Schmuck, 2005) and cytotoxic 
concentrations of the samples were excluded from data evaluation. 
Estrogenicity (MELN)  
The MELN assay, based on human cell line MCF-7 transfected with the luciferase gene under control 
of estrogenic response element, was used for the assessment of estrogenicity according to the 
previously described procedure (Kinani et al., 2010). Briefly, 100 µL of MELN cells suspension with a 
density of 8×104 cells/mL was seeded to a white 96-well plate in phenol red-free DMEM supplemented 
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with 3% DCC-FCS. After plating at 37°C for 24 h, the cells were exposed to the sampler extracts and 
incubated for a further 16 h. Before luminescence measurement, exposure medium was replaced with 
50 µL of medium supplemented with 0.3 mM luciferin. 17β-estradiol was used as the positive reference 
compound. The data were expressed as EC20 using a log-logistic dose-response model. Cell viability was 
assessed using the MTT assay. 
ARE-mediated oxidative stress response (AREc32)  
The MCF7 human breast carcinoma cell line-derived AREc32 assay was applied to assess the activation 
of the Nrf2 pathway (Wang et al., 2006), with the assay conducted according to Escher et al. (2012). 
The sampler extracts were blown to dryness, then re-suspended in DMEM with GlutaMAX™ with 10% 
FBS and serially diluted tert-Butylhydroquinone (tBHQ) was used as the positive reference compound. 
Cells were exposed in 96-well plates for 24 hours and then luminescence was detected using Luciferase 
Assay System (Promega E1500) according to the Promega protocol. Using a linear concentration-effect 
curve, the data was expressed as ECIR1.5 in units of REF, while the effect on cell viability detected with 
the MTS assay (Mosmann, 1983) expressed as EC10 was determined from a log-logistic concentration-
effect curve. ECIR1.5 was calculated using equation S3. 
𝐄𝐂𝐈𝐑𝟏.𝟓 =
𝟎.𝟓
𝒔𝒍𝒐𝒑𝒆
          Equation S1 
 
p53-mediated response (p53RE-bla)  
The CellSensor p53RE-bla HCT-116 assay (Life Technology, Australia) based on human colorectal 
carcinoma cell line HCT-116 was used to assess activation of p53 and was conducted according to Neale 
et al. (2015b). Briefly, the extracts were blown to dryness, then re-suspended in Opti-MEM with 0.5% 
dialyzed FBS and serially diluted. Eight microliters of the serially diluted extract were added to 32 µL 
of cells seeded at a density of 9.4×105 cells/mL in the black clear bottom 384-well plate. After 
incubating for 40 h at 37°C, 8 µL of FRET reagent with resazurin was added to each well and 
fluorescence was measured after incubating for 2.5 h at room temperature. Mitomycin was used as 
the positive reference compound with ECIR1.5 derived from a linear concentration-effect curve and cell 
viability EC10 derived from a log-logistic concentration-effect curve. 
NF-κB-mediated response (NF-κB-bla)  
The NF-κB-bla assay (Life Technology, Australia) based on the human monocyte THP-1 cell line, was 
used to assess the activation of NF-κB, which is indicative of inflammation response. The assay was 
performed as in Jin et al. (2015). The extracts were blown to dryness, then re-suspended in RPMI 1640 
media with 10% dialyzed FBS and serially diluted. Eight microliters of the serially diluted extract were 
added to 32 µL of cells seeded at a density of 6.3×105 cells/mL in the black clear bottom 384-well plate. 
After incubating for 24 h at 37°C, 8 µL of FRET reagent with resazurin was added to each well and 
fluorescence was measured after incubating for 2 h at room temperature. Tumor Necrosis Factor-alpha 
(TNFα) was used as the positive reference compound. ECIR1.5 values were derived from the linear 
concentration-effect curve, while the cell viability EC10 was derived from the log-logistic concentration-
effect curve.  
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Fig. S1 Map of the sampling cruise with the stretches and stationary exposure site (red dot); blue 
dots indicate active LVSPE sampling sites from Neale et al. (2015a). 
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Fig. S2 Overview of detected chemicals described in ToxCast database to be in/-active in 
eliciting the indicated effects.  
Inactive: AhR: 92 Active: AhR:  22 (19 %)
ER: 76 ER: 38 (33 %)
aAR: 100 aAR:  16 (14 %)
ARE: 73 ARE:  39 (35 %)
p53: 102 p53: 12 (11 %)
Inactive: AhR: 7478 Active: AhR:  828 (10%)
ER: 6948 ER: 1358 (16 %)
aAR: 7432 aAR: 874 (11 %)
ARE: 5826 ARE: 1696 (23 %)
p53: 7461 p53: 845 (10 %)
Analyzed chemicals: 267
Detected chemicals not in ToxCast: 91
Detected chemicals in ToxCast: 117
ToxCast: 9076
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Fig. S3 Percentage of the bioanalytical equivalents (BEQbio) explained by the detected chemicals 
(BEQchem) in samples from a dynamic passive sampling of the Danube river; SR silicone 
rubber samples, ED Empore discs samples; S1, 2 – stationary sampling site; 1-8 sampled 
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river stretches; for ARE in ED extracts, 18 main identified drivers of the effect are given 
(total 42 quantified active chemicals are provided in Tab. S4) 
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Fig. S4 p53-mediated mitomycin bioanalytical equivalents calculated from detected chemicals 
levels (BEQchem) in samples from a dynamic passive sampling of the Danube river; SR 
silicone rubber samples, ED Empore discs samples; S1, 2 – stationary sampling site; 1-8 
sampled river stretches  
 
 
 
Tab. S1 River stretches and stationary exposure localities sampled with passive samplers 
Stretch/
sample 
number 
Stretch start and 
end/stationary 
exposure site 
River km 
Sampling 
time span 
Mean water 
temperature 
[°C] 
Exposure 
time [d] 
Parameter 
ABb 
Water volume 
sampled by 
SR [L]a 
Water 
volume 
sampled 
by ED [L]b 
S1 
Stationary exposure 
1 
1,852 19.8.-23.8. 21.3 4 904 245 90 
S2 
Stationary exposure 
2 
1,852 23.8.-28.8. 21.3 5 772.6 264 97 
1 Passau–Bratislava 2,203-1,852 17.8.-22.8. 21.3 2 1208.8 236 62 
2 Bratislava–Budapest 1,852-1,632 22.8.-26.8. 22 1.2 1055 98 31 
3 Budapest–Vukovar 1,648-1,297 26.8.-2.9. 21.9 1.7 1179 151 51 
4 Vukovar–Belgrade 1,297-1,154 2.9.-6.9. 22.8 1.6 1223.8 117 49 
5 
Belgrade–Turnu-
Severin 
1,154-930 6.9.-10.9. 22.1 2 1041.2 112 51 
6 Turnu-Severin–Ruse 930-495 11.9.-17.9. 21.9 2 945.1 122 47 
7 Ruse–Braila 495-170 17.9.-21.9. 19.2 1.4 821.2 90 29 
8 Braila–Tulcea 170-71 21.9.-26.9. 18.7 1.3 791.2 73 26 
         
a Volume of water extracted by the SR sampler during exposure; volume is calculated from PRCs levels for a model compound with a 
molecular mass of 300. b Volume of water extracted by ED sampler during sampling; volume estimate based on a comparison of levels of 
10 PAHs in SR and samplers as described in 1.3.2. 
b Exposure specific parameter for calculation of Rs in equations 1;  for further details see Vrana et al.(submitted) 
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Tab. S2 Concentrations [pg/L] of chemicals detected in SR sampler extracts; PAHs - polycyclic aromatic hydrocarbons; BDE - brominate diphenyl ethers 
   Stationary exposure River stretch 
  Analyte [pg/L] CAS Number S1 S2 1 2 3 4 5 6 7 8 
PAHs Naphthalene 91-20-3 3,418 4,267 3,260 7,088 8,306 5,157 2,667 2,805 4,968 6,298 
 Biphenyl 92-52-4 485 1,264 423 504 4,440 1,236 688 549 616 740 
 Acenaphthylene 208-96-8 1,559 1,792 2,712 1,239 2,045 3,069 1,231 315 877 1,603 
 Acenaphthene 83-32-9 770 1,173 838 619 11,283 1,942 835 286 279 639 
 Fluorene 86-73-7 954 1,349 1,200 1,195 8,728 4,834 1,468 914 930 1,468 
 Phenantrene 85-01-8 1,917 2,800 3,086 2,441 5,527 14,755 2,717 2,178 1,975 3,502 
 Anthracene 120-12-7 185 206 346 307 571 388 222 144 158 267 
 Fluoranthene 206-44-0 3,527 4,440 2,672 3,516 4,659 2,464 2,654 2,371 1,463 2,386 
 Pyrene 129-00-0 1,767 2,399 1,609 2,151 3,292 2,192 1,847 1,244 1,470 2,231 
 Retene 483-65-8 996 1,155 617 599 358 243 258 119 137 187 
 Benzo(b)fluorene 243-17-4 223 251 192 181 267 154 170 97 105 163 
 Benzonaphthothiophene 205-43-6 82 130 132 71 89 68 61 35 64 83 
 Benzo(ghi)fluoranthene 203-12-3 144 176 112 117 123 77 105 93 89 119 
 Cyclopenta(cd)pyrene 27208-37-3 146 188 135 151 233 90 106 69 81 130 
 Benzo(a)anthracene 56-55-3 146 188 <6 <6 234 91 106 69 81 131 
 Triphenylene 217-59-4 360 442 403 403 371 295 402 384 392 425 
 Chrysene 218-01-9 266 375 283 238 307 140 187 136 149 202 
 Benzo(b)fluoranthene 205-99-2 158 129 87 109 106 41 79 100 51 63 
 Benzo(j)fluoranthene 205-82-3 64 79 17 33 41 15 24 39 <15 <15 
 Benzo(k)fluoranthene 207-08-9 34 27 <23 <23 <23 <23 <23 <23 <23 <23 
 Benzo(e)pyrene 192-97-2 120 146 92 103 88 44 79 55 79 65 
 Benzo(a)pyrene 50-32-8 <46 <46 <46 <46 <46 <46 70 <46 <46 <46 
 Perylene 198-55-0 82 <66 <66 <66 <66 <66 <66 <66 <66 <66 
 Indeno(123cd)pyrene 193-39-5 <21 <21 <21 <21 <21 <21 <21 <21 <21 <21 
 Dibenzo(ah)anthracene 53-70-3 <13 <13 <13 <13 <13 <13 <13 <13 <13 <13 
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 Dibenzo(ac)antracene 215-58-7  <18 <18 <18 <18 <18 <18 <18 <18 <18 <18 
 Benzo(ghi)perylene 191-24-2 21 25 <17 <17 <17 <17 <17 <17 <17 <17 
 Anthanthrene 191-26-4 <49 <49 <49 <49 <49 <49 <49 <49 <49 <49 
 Coronene 191-07-1 <62 <62 <62 <62 <62 <62 <62 <62 <62 <62 
 ΣPAHs 16 US EPA  14,721 19,169 16,092 18,902 45,058 35,073 14,083 10,562 12,402 18,790 
  ΣPAHs   17,342 23,000 18,215 21,063 51,067 37,296 15,975 12,002 13,965 20,704 
OCs PCB 28 7012-37-5 49 56 39 91 64 44 190 80 173 141 
 PCB 52 35693-99-3 82 94 69 121 59 53 121 16 102 98 
 PCB 101 37680-73-2 21 23 16 20 11 22 17 3.3 6.7 24 
 PCB 118 31508-00-6 4.2 4.5 3.0 3.9 2.3 2.7 3.5 4.0 2.5 2.9 
 PCB 153 35065-27-1 31 33 22 28 16 25 19 30 12 14 
 PCB 138 35065-28-2 22 24 16 21 12 19 14 19 8.5 10 
 PCB 180 35065-29-3 7.8 8.2 5.5 6.9 3.3 5.0 4.0 5.1 2.6 4.6 
 Σ PCB  217 244 171 291 167 172 369 158 307 295 
 PeCB 608-93-5 16 20 14 22 96 84 56 23 31 29 
 HCB 118-74-1 78 90 62 81 75 41 54 48 97 97 
 a-HCH 319-84-6 5.2 6.0 3.7 2.2 3.7 1.6 2.2 7.4 5.0 12.2 
 b-HCH 319-85-7 3.6 3.2 8.9 10 9.1 12 14 101 146 259 
 d-HCH 58-89-9 2.7 2.4 7.1 9.2 7.6 10 12 84 132 235 
 o,p'-DDE 3424-82-6 1.8 1.0 0.9 2.5 2.6 2.8 3.7 3.3 6.6 24.2 
 p,p'-DDE 72-55-9 34 33 18 58 54 54 72 71 165 512 
 o,p'-DDD 53-19-0  16 22 13 25 49 51 73 54 88 334 
 p,p'-DDD 72-54-8 22 39 21 30 60 49 66 69 125 313 
 o,p'-DDT 789-02-6 2.3 1.7 1.9 1.4 5.2 2.8 2.2 1.2 2.9 17.9 
 p,p'DDT 50-29-3 3.8 3.7 3.3 1.3 4.6 2.7 2.4 2.0 5.5 21.2 
 Σ DDT  83 103 61 119 181 165 220 202 396 1,240 
  Σ OCPs   188 223 156 244 372 313 358 465 808 1,872 
PBDEs BDE 28 41318-75-6 0.8 0.9 0.5 0.7 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 
 BDE 47 5436-43-1 0.8 0.7 6.8 <1.3 <1.3 <1.3 <1.3 <1.3 <1.3 <1.3 
 BDE 66 189084-61-5 <0.03 0.04 0.3 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 
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 BDE 100 189084-64-8 0.07 0.12 0.7 0.8 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 
 BDE 99 60348-60-9 0.12 0.31 2.0 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
 BDE 85 182346-21-0 0.04 0.03 0.4 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 
 BDE 154 207122-15-4 0.22 0.42 1.2 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 <0.6 
 BDE 153 68631-49-2 <0.09 0.21 0.5 1.0 <0.3 <0.3 <0.3 <0.3 <0.3 <0.3 
 BDE 183 207122-16-5 1.84 3.30 10 <4.3 <4.3 <4.3 <4.3 <4.3 <4.3 <4.3 
 Σ WFD BDEs  1.99 2.61 11.6 2.5 n.d. n.d. n.d. n.d. n.d. n.d. 
  Σ BDEs   3.86 5.98 22.2 2.5 n.d. n.d. n.d. n.d. n.d. n.d. 
Alkylphenols Bisphenol A 80-05-7 674 644 338 309 370 494 446 <0.2 251 310 
 4-t-octylphenol 140-66-9  93 107 184 145 198 362 138 72 137 85 
 4-nonylphenol 104-40-5  2,165 2,775 5,226 5,816 7,391 9,156 7,928 3,453 6,890 5,841 
  Σ Alkylphenols   2,932 3,526 5,749 6,270 7,959 10,012 8,511 3,525 7,278 6,236 
Musks Cashmeran 33704-61-9 1,526 1,991 658 977 663 434 <341 <341 <341 <341 
 Celestolide 13171-00-1 40 62 <34 <34 <34 54 <34 <34 <34 <34 
 Phantolide 15323-35-0 <31 <31 <31 <31 <31 <31 <31 <31 <31 <31 
 Traseolide 68140-48-7 87 129 68 70 75 81 74 39 69 <21 
 Galaxolide 1222-05-5 17,021 25,063 10,104 10,848 16,722 15,831 22,312 9,183 12,096 8,864 
 Tonalide 1506-02-1 1,473 2,648 1,069 976 1,521 2,003 3,008 837 1,307 868 
  Σ Musks   18,582 27,839 11,240 11,894 18,317 17,915 25,395 10,060 13,471 9,732 
NBFRs TBECH 3322-93-8 0.941 1.488 1.275 0.756 0.807 0.604 1.243 0.323 0.225 0.230 
 p-TBX 23488-38-2 0.018 0.012 0.030 0.039 0.056 0.015 <0.007 <0.007 <0.012 0.056 
 BATE 3728-89-5 0.655 0.272 0.418 0.242 0.054 0.083 0.163 0.035 0.054 0.100 
 TBCO 3194-57-8 <0.021 <0.019 <0.03 <0.061 <0.037 <0.039 <0.037 <0.04 <0.065 <0.072 
 PBBZ 608-90-2 0.060 0.030 0.325 0.083 0.097 0.065 0.056 0.066 0.078 0.156 
 TBCT 39569-21-6 0.006 <0.005 0.017 <0.016 <0.01 <0.01 <0.01 <0.011 <0.017 0.110 
 PBT 87-83-2 0.090 0.071 0.127 0.136 1.299 0.364 0.184 0.170 0.381 0.565 
 PBEB 85-22-3 0.04 <0.0016 <0.0024 <0.0049 0.1 <0.0031 <0.0029 <0.0032 <0.0052 0.2 
 DPTE 35109-60-5 3.73 8.61 9.4 2.0 <0.17 <0.18 <0.17 <0.18 <0.3 <0.33 
 HBB 87-82-1 0.14 0.13 0.19 <0.028 0.25 0.30 <0.017 <0.018 0.52 0.67 
 PBBA 59947-55-1 <0.037 <0.034 <0.053 <0.107 <0.064 <0.067 <0.064 <0.069 <0.113 <0.125 
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 HCDBCO 51936-55-1 <0.023 <0.021 <0.033 <0.067 <0.041 <0.042 <0.04 <0.044 <0.071 <0.079 
 BTBPE 37853-59-1 0.26 0.12 0.28 <0.03 <0.018 <0.019 <0.018 <0.019 <0.032 <0.035 
 s-DP 13560-89-9 1.08 1.49 9.0 15.2 10.8 6.3 13.0 17.9 2.4 5.3 
 a-DP 13560-89-9 0.47 0.80 2.5 6.3 2.0 1.6 2.2 3.2 1.8 4.4 
  Σ NBFRs   7.49 13.02 23.5 24.7 15.4 9.3 16.8 21.6 5.4 11.8 
Alkyl 
phosphates Triisobutyl phosphate 126-71-6 57,464 81,680 38,251 59,746 52,243 43,502 57,037 94,150 97,702 101,181 
 Tributyl phosphate  126-73-8 5,067 8,584 3,289 15,329 4,591 4,048 6,574 8,745 6,950 9,694 
 Tris(2-Chloroethyl)phosphate 115-96-8 <396 <360 <420 <418 <390 <397 <390 <433 <380 <392 
 
Tris(1-Chloro-2-
propyl)phosphate 13674-84-5 56,811 56,211 31,360 35,714 37,372 22,414 31,220 37,939 28,631 32,109 
 Dibutyl phenyl phosphate 2528-36-1 254 311 326 151 141 94 146 108 114 123 
 Butyl diphenyl phosphate 2752-95-6 <27 110 92 <77 <46 <48 <46 <50 <81 <90 
 
Tris(1,3-Dichloro-2-
propyl)phosphate 13674-87-8 7,209 13,399 6,752 3,738 5,814 2,700 2,803 3,585 4,325 3,729 
 Tris(2-butoxyethyl)phosphate  78-51-3 14,211 23,996 17,628 6,554 10,276 5,738 6,299 2,447 1,678 1,604 
 Tris(2-ethylhexyl)phosphate 78-42-2 <113 <105 <164 <329 <199 <207 <199 <214 <349 <386 
 Triphenyl phosphate 115-86-6 811 2,208 913 344 567 427 275 181 255 202 
 2-Ethylhexyldiphenyl phosphate 1241-94-7 45 142 108 52 82 60 65 <8 <13 <15 
 Tri-o-tolyl phosphate 78-30-8 17 <4 20 57 14 31 15 67 27 37 
 Tri-m-tolyl phosphate 228-312-4  34 83 63 47 29 20 12 11 <9 17 
 Tri-p-tolyl phosphate 1038-95-5 <4 <4 15 32 12 11 <7 <7 <12 <13 
 Σ Alkylphosphates   141,923 186,725 98,815 121,763 111,142 79,046 104,446 147,234 139,681 148,697 
 
  
18 
 
 
Tab. S3 Concentrations [pg/L] of chemicals detected in ED sampler extracts 
   Stationary exposure River stretch 
  Analyte  CAS Number S1 S2 1 2 3 4 5 6 7 8 
Pharmaceuticals  Ampicillin 69-52-3 89 < 60 < 100 < 190 136 172 216 < 120 238 < 260 
ATBs Azithromycin 104491-80-7 < 20 < 20 < 30 < 60 < 40 < 40 < 40 < 40 < 70 < 70 
 Ciprofloxacin 85721-33-1 21 152 26 46 53 92 88 143 128 < 30 
 Clarithromycin 116836-41-0 < 160 < 170 < 240 < 520 < 390 < 310 < 310 < 400 < 590 < 570 
 Clindamycine 18323-44-9 737 1,249 776 1,855 1,375 983 1,492 1,414 1,139 914 
 Difloxacin 91296-86-5 < 10 < 10 < 20 < 40 < 20 < 20 < 30 < 20 < 40 < 50 
 Enoxacin 206873-63-4 103 24 42 75 41 66 < 30 116 69 107 
 Enrofloxacin 112732-17-9 < 10 < 10 < 20 < 40 < 30 < 30 < 30 < 30 < 50 < 50 
 Erythromycin 114-07-8 < 150 < 150 < 230 < 490 < 370 < 290 < 290 < 380 < 550 < 530 
 Flumequine 143984-63-8 22.33 8.26 < 10 < 40 < 20 < 20 < 20 < 30 < 50 64.8 
 Levofloxacin 100986-85-4 < 10 < 10 < 20 < 40 < 20 < 20 < 30 < 20 < 40 < 50 
 Lomefloxacin 98079-51-7 < 10 < 10 < 20 < 40 < 30 < 30 < 30 < 30 < 50 < 50 
 Norfloxacin 68077-27-0 < 10 < 10 < 10 < 30 < 20 < 20 27 < 20 < 30 < 30 
 Oxolinic acid 14698-29-4 44 61 18 114 49 20 51 127 148 103 
 Oxytetracycline 79-57-2 < 130 < 130 < 190 < 360 < 240 < 250 < 260 < 230 < 450 < 460 
 Penicillin_V 132-98-9 < 20 < 10 < 20 < 50 < 30 < 30 < 30 < 40 < 70 < 60 
 Roxithromycin 80214-83-1 < 90 < 90 < 130 < 240 < 140 < 140 < 150 < 170 < 280 < 280 
 Sulfadiazine 116-44-9 402 754 485 749 1,061 512 844 < 360 828 < 760 
 Sulfadimethoxine 1037-50-9 33 20 < 10 36 26 25 55 55 < 50 80 
 Sulfamerazine 127-79-7 279 320 < 360 < 680 963 < 430 844 < 440 < 760 < 910 
 Sulfamethazine 1981-58-4 458 651 840 3,060 3,909 2,090 2,611 2,553 18,326 12,078 
 Sulfamethizole 144-82-1 301 217 533 < 420 < 240 328 393 717 < 480 1,448 
 Sulfamethoxazole 129378-89-8 922 539 1,297 2,015 1,190 1,131 1,637 1,386 2,454 2,542 
 Sulfamethoxypyridazine 80-35-3 580 < 200 517 684 727 < 390 1,748 464 < 690 2,324 
 Sulfamoxole 729-99-7 458 372 < 290 1,725 884 410 805 443 2,071 1,067 
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 Sulfaphenazole 526-08-9 15 26 13 52 26 51 24 < 30 < 50 50 
 Sulfapyridine 144-83-2 8,059 7,796 6,465 12,304 12,572 11,453 10,780 5,127 7,593 8,154 
 Sulfaquinoxaline 59-40-5 23 30 32 49 65 < 20 47 < 20 159 < 40 
 Sulfasalazine 599-79-1 123 13 60 182 51 59 35 112 41 331 
 Sulfathiazole 158269-46-6 < 250 < 200 < 320 < 620 < 350 < 390 < 390 < 400 < 690 < 840 
  Trimethoprim 738-70-5 < 250 < 200 372 977 < 350 < 390 < 390 < 400 < 690 < 840 
Cardiovascular Amiodarone 1951-25-3 < 150 < 190 < 240 < 490 < 390 < 330 < 310 < 420 < 660 < 720 
 Atenolol 29122-68-7 < 180 217 < 240 846 < 260 < 290 353 < 300 < 520 < 610 
 Bisoprolol 66722-44-9 357 341 < 230 < 420 < 260 < 270 < 270 < 270 < 480 < 570 
 Cilazapril 88768-40-5 < 10 < 10 < 10 < 20 < 10 < 10 < 10 < 20 < 30 < 30 
 Diltiazem 144604-00-2 246 258 259 < 460 432 287 353 < 360 725 610 
 Dipyridamole 58-32-2 301 465 < 370 < 780 < 570 < 470 609 738 < 860 < 840 
 Disopyramide 3737-09-5 < 10 < 10 < 20 < 30 < 20 < 20 < 20 < 20 < 40 < 40 
 Eprosartan 133040-01-4 51 145 115 260 139 84 55 63 207 324 
 Flecainide 1403764-72-6 < 10 < 10 < 10 < 30 < 20 < 20 < 20 < 20 < 30 < 30 
 Irbesartan 138402-11-6 10,002 10,656 9,907 14,583 16,442 8,216 7,952 4,241 6,695 4,839 
 Metoprolol 13484-40-7 1,161 558 291 1,172 1,355 1,106 942 < 270 897 3,200 
 Sotalol 27948-47-6 < 180 < 140 < 240 < 460 < 280 < 310 < 290 < 300 < 520 < 610 
 Telmisartan 144701-48-4 1,708 2,241 1,018 2,669 2,986 1,578 1,335 2,152 1,967 1,943 
 Valsartan 137862-53-4 190 85 158 163 295 96 130 68 273 110 
  Verapamil 152-11-4 167 < 120 < 190 < 420 < 290 < 250 < 240 < 320 < 450 < 420 
Psychoactive Alprazolam 28981-97-7 647 743 323 1,660 1,709 1,045 1,178 2,110 2,830 1,753 
 Amitriptyline 337376-15-5 < 130 176 < 210 < 460 334 < 270 < 270 < 340 < 480 < 500 
 Bupropion 31677-93-7 659 475 372 < 420 334 < 270 < 260 < 270 < 480 < 570 
 Carbamazepine 298-46-4 13,211 11,300 11,017 18,622 16,482 10,950 16,263 17,561 23,028 20,456 
 Citalopram 128196-01-0 < 10 18 13 39 26 < 20 < 20 34 48 < 30 
 Clonazepam 106955-87-7 15 11 53 117 22 47 47 76 66 110 
 Codeine 70982-46-6 357 237 404 911 < 260 881 275 < 270 725 < 570 
 Donepezil 120011-70-3 17 < 10 < 10 26 22 < 10 < 10 25 < 30 < 30 
 Fluoxetine 100568-03-4 < 50 < 50 < 70 < 120 < 80 < 80 < 80 < 90 < 130 < 150 
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 Flupentixol 2709-56-0 27 27 37 78 114 < 30 51 91 197 91 
 Fluphenazine 5002-47-1 268 114 66 133 < 60 82 334 165 190 278 
 Haloperidol 337376-15-5 10 < 10 11 < 30 < 20 < 20 < 20 < 20 < 40 < 40 
 Chlorprothixene 113-59-7 56 58 226 < 130 165 88 161 97 < 150 236 
 Levomepromazine 60-99-1 < 100 < 100 < 150 < 320 < 240 195 < 190 < 250 < 350 < 340 
 Maprotiline 10262-69-8 < 90 134 < 110 299 275 < 140 < 140 274 266 331 
 Meclozine 1104-22-9 < 20 < 20 36 < 50 65 < 40 37 219 166 152 
 Memantine 19982-08-2 13 8 < 0 < 10 12 < 10 12 < 10 < 20 < 20 
 Mianserin 21535-47-7 < 130 < 130 259 < 420 < 310 < 250 < 260 < 340 < 480 < 460 
 Mirtazapine 61337-67-5 < 10 < 10 < 20 < 30 < 20 < 20 < 20 < 20 < 40 < 40 
 Nefazodone 337376-15-5 < 70 < 60 < 90 < 170 < 110 < 110 < 110 < 120 < 180 < 200 
 Oxazepam 35295-88-6 9,310 7,641 4,477 6,543 6,306 4,016 5,144 3,966 5,142 5,144 
 Paroxetine 110429-35-1 32 8 < 10 55 29 20 59 89 114 95 
 Perphenazine 58-39-9 268 165 323 < 170 < 100 225 161 < 120 < 200 < 200 
 Risperidone 106266-06-2 < 20 < 20 < 20 < 40 < 30 < 30 < 30 < 30 < 50 < 50 
 Ropinirole 337376-15-5 < 160 < 120 < 210 < 390 < 240 < 250 < 260 < 250 < 450 < 530 
 Sertaline 79617-96-2 290 77 91 192 171 328 120 < 110 656 < 180 
 Tetracycline 60-54-8 < 190 < 190 < 260 < 490 < 310 < 350 < 330 < 320 < 590 < 610 
 Tramadol 123154-38-1 179 176 115 215 161 107 118 103 124 103 
 Trihexyphenidyl 144-11-6 < 80 < 70 < 100 < 190 < 120 < 120 < 130 < 140 < 200 < 230 
  Venlafaxine 93413-44-6 80 53 37 65 65 35 41 44 45 < 30 
Antihistamins Azelastine 58581-89-8 < 70 < 60 < 80 < 160 < 100 < 100 < 110 < 110 < 170 < 190 
 Clemastine 14976-57-9 < 130 < 120 < 180 < 360 < 200 < 200 < 220 < 250 < 410 < 420 
 Cyproheptadine 129-03-3 123 < 110 < 180 < 360 < 280 348 242 < 270 583 < 380 
 Desloratadine 100643-71-8 < 10 < 10 < 10 < 30 < 20 < 20 < 20 < 20 < 30 < 30 
 Diphenhydramine 147-24-0 9 < 0 < 0 < 10 < 10 < 10 < 10 < 10 < 20 < 20 
 Hydroxyzine 10246-75-0 < 70 91 116 < 170 112 < 110 < 120 < 120 < 180 < 210 
 Loperamide 34552-83-5 < 120 < 120 < 180 < 390 < 290 < 230 < 240 < 300 < 450 < 420 
  Orphenadrine 337376-15-5 123 < 100 158 < 330 < 240 < 190 < 200 < 250 < 350 < 350 
Antifungals Clotrimazole 117829-71-7 3,014 3,304 3,249 5,859 7,190 5,368 9,130 7,595 9,146 5,486 
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 Econazole 1069-66-5 47 30 44 62 59 < 30 < 30 < 30 93 213 
 Fluconazole 123631-92-5 324 310 242 423 413 389 452 401 725 648 
 Itraconazole 84625-61-6 < 70 < 90 < 110 < 220 < 180 < 160 < 150 < 200 < 310 < 340 
 Ketoconazole 142128-59-4 625 1,136 485 1,823 373 2,623 746 2,131 < 480 2,858 
 Miconazole 22832-87-7 50 68 57 124 47 59 71 196 466 91 
 Sulconazole 61318-90-9 39 51 45 < 50 65 37 161 143 152 < 80 
  Terbutaline 23031-25-6 < 170 < 130 < 230 < 420 < 260 < 270 < 270 < 270 < 480 < 570 
Antidiabetics Bromocriptine 22260-51-1 6.70 4.13 < 0 42.3 11.8 34.8 19.6 21.1 24.2 26.7 
 Glibenclamide 10238-21-8 25 < 20 32 < 50 86 < 30 < 30 < 40 72 < 70 
 Glimepiride 29094-61-9 < 30 < 30 < 40 < 90 < 70 < 60 < 60 < 80 < 120 < 130 
  Repaglinide 135062-02-1 < 110 < 100 < 160 < 290 < 170 < 180 < 180 < 200 < 340 < 340 
Statins Atorvastatin 110862-48-1 56 < 40 < 60 < 110 < 70 < 70 < 70 84 < 120 < 130 
 Bezafibrate 41859-67-0 37 102 39 49 53 156 310 95 211 217 
 Fenofibrate 49562-28-9 99 207 226 273 1,179 820 864 186 380 < 220 
  Rosuvastatin 1094100-06-7 97 9 21 78 28 55 45 53 < 20 290 
Cancer treatment Flutamide 13311-84-7 < 90 < 110 < 150 < 290 < 240 < 200 < 190 < 250 < 410 < 420 
 Fulvestrant 129453-61-8 < 40 < 50 < 60 < 130 < 100 < 90 < 80 < 110 < 180 < 190 
  Tamoxifen 10540-29-1 < 10 < 20 < 20 < 50 < 40 < 30 < 30 < 40 < 70 < 70 
NSAID Diclofenac 15307-86-5 < 30 < 40 < 50 < 110 < 90 < 70 < 70 < 90 < 150 < 160 
Diuretic Furosemide 106391-48-4 < 50 < 30 < 50 < 140 122 < 100 < 90 < 110 < 200 < 200 
Other Alfuzosin 337376-15-5 < 160 < 120 < 210 < 420 < 240 < 270 < 260 < 270 < 450 < 530 
 Naloxone 465-65-6 290 248 < 230 < 460 < 260 533 < 270 295 < 520 < 610 
 Ranitidine 66357-35-5 < 160 < 120 < 210 < 390 < 240 < 250 < 260 < 250 < 450 < 530 
  Σ Pharmaceuticals   57,256 54,175 45,799 81,306 80,803 57,203 69,470 55,973 89,406 78,869 
CUPs Acetochlor 34256-82-1 11 45 < 3.2 < 6.5 57 42 138 498 592 965 
 Alachlor 15972-60-8 21 45 < 16.3 < 66.1 < 19.8 < 20.7 29 < 42.6 101 56 
 Atrazine 1912-24-9 3,025 4,339 7,349 4,703 6,995 3,400 4,817 4,767 18,295 8,482 
 Azinphos methyl 86-50-0 < 2.2 < 2.1 < 3.2 < 6.5 < 3.9 < 4.1 < 3.9 < 4.2 < 6.9 < 7.6 
 Carbaryl 63-25-2 < 1.1 < 1 < 1.6 < 3.3 < 2 < 2 < 2 < 2.1 < 3.5 < 3.8 
 Carbendazim 10605-21-7 11 15 20 12 25 17 25 22 82 40 
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 Chlorpyrifos 2921-88-2 179 257 289 117 351 188 415 329 1,482 608 
 Chlorsulfuron 64902-72-3 < 2.2 < 2.1 < 3.2 < 6.5 < 3.9 < 4.1 < 3.9 < 4.2 14 < 7.6 
 Chlortoluron 15545-48-9 1,815 1,717 3,463 2,118 2,439 603 687 673 1,992 780 
 Clopyralid 1702-17-6 < 22.2 < 20.8 < 32.5 < 66.1 < 39.5 < 41.2 < 39.7 < 42.6 < 69.7 < 76.2 
 Diazinon 333-41-5 141 165 116 144 245 299 677 608 1,415 1,363 
 Dimethachlor 50563-36-5 22 242 36 44 130 73 120 20 116 91 
 Dimethoate 60-51-5 24 33 77 32 34 18 37 24 92 43 
 Disulfoton 298-04-4 < 1.1 < 1 < 1.6 < 3.3 < 2 < 2 < 2 < 2.1 < 3.5 < 3.8 
 Diuron 330-54-1 1,228 1,825 2,409 1,238 1,770 804 1,266 1,079 3,533 1,504 
 Fenitrothion 122-14-5 < 66.6 < 62.2 < 97.6 < 198.6 < 118.6 < 123.8 < 119 < 127.9 < 208.8 < 228.2 
 Fenoxaprop ethyl 66441-23-4 < 1.1 < 0.4 < 0.6 < 1.3 < 2 < 0.8 < 2 < 2.1 3 < 3.8 
 Fenpropimorph 67564-91-4 10 13 15 < 1.3 5 3 2 < 0.8 < 3.5 < 1.5 
 Florasulam 145701-23-1 5.13 5.99 9.1 7.2 9.8 2.0 3.5 5.9 20.0 4.6 
 Fluroxypyr 69377-81-7 < 5.6 < 5.2 < 8.1 < 16.6 < 9.8 238 428 < 10.8 < 17.3 < 19.1 
 Fonofos 944-22-9 < 2.2 < 2.1 < 3.2 < 6.5 < 3.9 < 4.1 < 3.9 < 4.2 < 6.9 < 7.6 
 Isoproturon 34123-59-6 632 816 1,416 783 977 436 723 569 1,856 728 
 Malathion 121-75-5 < 5.6 14 23 18 16 47 214 31 89 35 
 Metamitron 41394-05-2 < 5.6 < 5.2 40 < 16.6 75 11 10 21 61 < 19.1 
 Metazachlor 67129-08-2 149 483 374 204 418 213 327 134 487 1,026 
 Metolachlor 51218-45-2 1,238 1,889 1,988 1,470 1,882 1,218 1,397 1,530 3,210 2,129 
 Metribuzin 21087-64-9 142 218 < 3.2 26 205 193 81 156 224 146 
 Parathion methyl 298-00-0 < 44.4 2,563 2,361 256 2,483 1,592 3,797 4,756 5,479 7,795 
 Pendimethalin 40487-42-1 95 172 162 113 200 88 95 69 97 53 
 Phosmet 732-11-6 < 2.2 < 5.2 17.1 8.5 16.9 6.1 5.9 12.7 11.7 < 19.1 
 Pirimicarb 23103-98-2 31 41 74 46 72 36 32 20 45 11 
 Prochloraz 67747-09-5 78 141 124 118 130 52 128 111 197 126 
 Propiconazole 60207-90-1 3,745 6,719 5,250 3,208 5,462 2,793 3,192 3,484 6,508 4,284 
 Pyrazon 216-920-2  67 87 175 195 296 120 191 208 831 412 
 Simazine 122-34-9 451 651 968 488 739 309 498 575 2,015 1,362 
 Tebuconazole 107534-96-3 3,114 4,490 3,331 2,864 3,911 2,458 3,508 4,169 7,473 5,174 
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 Temephos 3383-96-8 3.80 1.65 < 1 < 2 3.9 < 1.2 3.1 1.3 2.8 3.0 
 Terbufos 13071-79-9 272 270 313 386 1,125 478 2,296 2,676 3,519 1,532 
 Terbuthylazin 5915-41-3 1,029 1,481 2,708 1,885 2,409 1,320 1,873 1,818 7,241 3,198 
 Tribenuron-methyl 101200-48-0 3.13 8.47 41.7 8.5 29.1 8.2 17.7 7.2 56.6 11.4 
  Σ CUPs   17,543 28,746 33,152 20,492 32,509 17,067 27,033 28,373 67,140 41,961 
Alkylphenols Bisphenol A 80-05-7 5,426 5,771 6,821 6,207 7,862 17,471 27,537 12,921 14,894 14,449 
 4-t-octylphenol 140-66-9  83 101 191 334 178 485 143 98 169 94 
 4-nonylphenol 104-40-5  2,121 1,918 5,214 5,943 7,169 8,355 6,833 7,963 7,336 5,274 
  Σ Alkylphenols   7,630 7,790 12,225 12,484 15,209 26,311 34,513 20,982 22,399 19,817 
Steroids Estriol 50-27-1 <8.93 <8.26 <25.86 <52.08 47 161 234 46 38 66 
 17α-estradiol 57-91-0 <17.86 <16.52 <25.86 <52.08 <31.43 <32.78 <31.42 <33.76 <27.61 <30.48 
 17β-estradiol 50-28-2 <17.86 <16.52 <25.86 <52.08 43 43 97 <33.76 57 56 
 17α-ethinyl-estradiol 57-63-6 <25.86 <25.86 <25.86 <25.86 <25.86 <25.86 <25.86 <25.86 <25.86 <25.86 
 Estrone 53-16-7 176 198 201 351 492 422 820 352 675 694 
  Σ Steroids   176 198 201 351 582 626 1,151 398 770 816 
PAHs Naphthalene 91-20-3 129 426 1,152 3,531 <3 875 790 1,963 1,725 2,646 
 Biphenyl 92-52-4 92 156 204 299 981 172 195 148 112 209 
 Acenaphthylene 208-96-8 59 79 164 115 661 92 94 59 47 103 
 Acenaphthene 83-32-9 72 129 175 140 2,445 195 125 72 30 155 
 Fluorene 86-73-7 224 308 379 403 3,363 1,395 424 259 236 585 
 Phenanthrene 85-01-8 1,121 1,507 2,601 2,048 5,136 10,235 2,098 1,948 1,458 3,403 
 Anthracene 120-12-7 79 114 375 277 788 294 161 108 105 294 
 Fluoranthene 206-44-0 1,972 2,134 1,967 2,504 3,633 1,542 1,832 1,515 1,152 1,953 
 Pyrene 129-00-0 1,005 1,125 1,162 1,430 2,712 1,311 1,258 874 1,005 1,630 
 Retene 483-65-8 482 439 328 272 605 98 128 127 179 123 
 Benzo(b)fluorene 243-17-4 104 114 115 127 <12 119 116 80 51 99 
 Benzonapthothiophene 205-43-6 63 71 101 51 <7 58 64 40 51 65 
 Benzo(ghi)fluoranthene 203-12-3 95 97 82 105 <5 75 89 85 81 91 
 Cyclopenta(cd)pyrene 27208-37-3 <3 <2 <4 <7 <4 <5 <4 <5 <8 <9 
 Benzo(a)anthracene 56-55-3 99 114 114 95 281 86 101 61 58 118 
24 
 
 Triphenylene 217-59-4 264 273 380 347 795 304 358 373 366 435 
 Chrysene 218-01-9 189 211 231 166 1,012 278 169 143 120 142 
 Benzo(b)fluoranthene 205-99-2 67 47 <12 <24 <14 <15 <14 <15 <25 <28 
 Benzo(j)fluoranthene 205-82-3 36 36 <12 <24 <14 <15 <14 <16 <25 <28 
 Benzo(k)fluoranthene 207-08-9 22 20 <13 <26 <16 <16 <16 <17 <27 <30 
 Benzo(e)pyrene 192-97-2 64 62 64 74 <12 63 64 54 <21 <24 
 Benzo(a)pyrene 50-32-8 7 11 <14 <28 <17 <18 <17 <18 <29 <33 
 Perylene 198-55-0 18 19 <13 <26 <16 <17 <16 52 117 194 
 Indeno(123cd)pyrene 193-39-5 <8 <7 <11 <22 <13 <14 <13 <14 <23 <26 
 Dibenzo(ah)anthracene 53-70-3 <9 <8 <13 <26 <16 <16 <16 <17 <27 <30 
 Dibenzo(ac)anthracene 215-58-7  <9 <8 <13 <26 <16 <16 <16 <17 <27 <30 
 Benzo(ghi)perylene 191-24-2 8 7 <7 <15 <9 <9 <9 <9 <15 <17 
 Anthanthrene 191-26-4 <12 <11 <18 <36 <22 <23 <22 <23 <38 <42 
 Coronene 191-07-1 <14 <13 <21 <42 <26 <27 <26 <27 <45 <49 
  Σ PAHs   6,271 7,498 9,594 11,984 22,411 17,190 8,065 7,962 6,893 12,245 
Sterols Brassicasterol 474-67-9 5,465 3,631 1,253 1,927 3,042 2,293 2,479 3,925 1,519 1,166 
 Campesterol 474-62-4 5,882 5,829 3,172 5,128 <196.44 3,988 5,480 4,972 7,294 6,127 
 Desmosterol 313-04-2 977 1,135 1,042 <325.51 964 302 618 603 1,160 741 
 Ergosterol 57-87-4 <66.98 324 <96.97 <195.31 <117.86 <122.93 <117.81 <126.58 <207.08 <228.6 
 Fucosterol 17605-67-3 2,044 1,204 1,422 <325.51 1,177 1,120 1,034 1,301 1,260 1,655 
 Cholestanol 80-97-7 2,114 2,284 <161.62 <325.51 2,281 <204.89 <196.35 <210.97 <345.13 2,915 
 Cholesterol 57-88-5 20,035 23,144 10,522 15,737 18,385 11,067 22,500 17,751 19,607 14,364 
 Sitosterol 83-46-5 16,120 <20.65 5,990 10,776 9,077 6,421 6,775 8,936 7,298 12,106 
 Spinasterol 481-18-5 9,786 7,531 2,196 7,967 7,497 3,159 2,577 6,274 5,788 <381.01 
 Stigmastanol 19466-47-8 805 905 <161.62 <325.51 <196.44 889 <196.35 627 <345.13 <381.01 
 Stigmasterol 83-48-7 8,782 6,791 4,286 4,429 7,572 5,514 5,995 1,821 5,072 11,735 
  Σ Sterols   72,010 52,776 29,885 45,964 49,994 34,753 47,458 46,209 48,996 50,809 
Flavonoids Apigenin 520-36-5 18.98 18.07 12.9 14.6 24.6 34.8 20.6 21.1 19.0 19.1 
 Biochanin A 491-80-5 30.70 35.11 22.6 9.8 11.8 11.3 3.9 <0.04 3.5 3.8 
 Coumestrol 479-13-0 <0.22 <0.21 <0.32 <0.65 <0.39 <0.41 <0.39 <0.42 <0.69 <0.76 
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 Daidzein 486-66-8 73 108 93 76 88 488 595 162 255 404 
 Equol 94105-90-5 207 250 318 150 138 1,332 821 268 2,571 9,449 
 Formononetin 485-72-3 268 302 328 270 177 163 231 141 178 389 
 Genistein 446-72-0 33 53 47 21 268 585 159 28 47 65 
 Naringenin 266-769-1 166 188 132 94 98 302 160 72 138 <0.08 
  Σ Flavonoids   798 955 954 636 806 2,916 1,990 693 3,211 10,329 
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Tab. S4  Sum molar concentrations of groups of chemicals detected in samples from dynamic passive sampling  
1-8 samples from mobile sampling of river stretches; SR silicone rubber sampler, ED Empore™ disc sampler; No. number of analyzed chemicals in the category; 
<LOD concentrations below the limit of detection; for individual chemical identification see SI.  
Sampler Chemicals (pmol L-1) No. S1 S2 1 2 3 4 5 6 7 8 
ED ATBs 31 48.34 46.17 43.51 89.63 87.56 66.47 81.53 46.24 122.21 108.15 
 Cardiovascular 15 31.57 33.97 26.78 45.09 48.20 24.97 26.34 15.84 23.62 22.23 
 Psychoactive 30 98.12 82.94 69.93 114.01 103.54 70.08 94.72 98.63 132.72 114.32 
 Antihistamins 8 0.92 0.24 0.90 <LOD 0.30 1.21 0.84 <LOD 2.03 <LOD 
 Antifungals 8 11.32 13.10 11.49 22.26 23.33 22.01 29.93 28.18 30.63 24.18 
 Antidiabetics 4 0.06 0.01 0.07 0.06 0.19 0.05 0.03 0.03 0.18 0.04 
 Statins 4 0.57 0.86 0.76 0.97 3.44 2.76 3.30 0.98 1.63 0.89 
 Other pharm.1 8 0.89 0.76 <LOD <LOD 0.37 1.63 <LOD 0.90 <LOD <LOD 
 CUPs 40 67.55 107.47 132.15 81.52 126.65 65.13 102.24 106.26 266.67 160.25 
 Alkylphenols 3 0.65 0.73 0.74 1.30 2.14 2.28 4.20 1.46 2.84 3.00 
 PAHs 29 33.80 34.47 54.47 55.78 67.84 116.80 152.33 93.21 99.35 87.69 
 Steroids 5 31.78 39.30 53.14 71.50 123.13 96.11 44.11 46.47 39.98 71.16 
 Phytosterols 11 178.93 132.94 74.58 117.35 124.81 86.46 119.31 115.55 122.70 126.43 
  Flavonoids 8 3.05 3.66 3.69 2.44 3.06 11.47 7.85 2.72 13.04 42.36 
             
SR PAHs 29 100.66 133.97 108.06 130.08 315.96 223.61 93.50 70.97 87.78 128.33 
 PCBs 7 0.72 0.80 0.56 0.99 0.58 0.57 1.32 0.54 1.11 1.05 
 OCPs 12 0.63 0.75 0.53 0.82 1.28 1.07 1.20 1.55 2.68 6.06 
 BDEs 9 0.01 0.02 0.06 0.01 <LOD <LOD <LOD <LOD <LOD <LOD 
 NBFRs 15 0.01 0.02 0.04 0.04 0.03 0.02 0.03 0.03 0.01 0.02 
 Musks 6 144.03 215.80 46.69 50.77 74.10 138.94 <LOD <LOD <LOD <LOD 
  Alkylphenols 3 13.23 15.93 26.09 28.45 36.12 45.47 38.60 16.02 33.03 28.28 
 Alkylphosphates 14 464.26 610.68 316.42 418.14 369.38 269.61 358.08 517.79 495.86 528.22 
1 furosemide, alfuzosin, naloxone, ranitidine 
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Tab. S5  Relative effect potencies (REPs) of detected compounds  
REPs that were used for calculation of chemical data-based bioanalytical equivalents (BEQchem) were obtained either from experiments from the current study or from 
literature. Literature was preferentially searched for REP values specific for the bioassays employed in the current study. Where no such REPs were available, we used data 
from analogical bioassays as indicated. When there was more than one relevant literature source available, geometrical mean of REP value was calculated.  
 
Assay Activation of AhR Activation of PXR Activation of ER Inhibition of AR Oxidative stress response Activation of p53 
No. chemicals 23 27 26 22 11 12 
Reference 
compound 
2,3,7,8-Tetrachlorodibenzo-p-
dioxin (TCDD) 
SR 12813 17β-Estradiol Flutamide tert-Butylhydroquinone (tBHQ) Mitomycin 
 
Chemical REP   based on 
  
Chemical REP based on  Chemical  REP 
  
based on 
  
Chemical REP based on  Chemical REP   based on   Chemical REP   based on  
 
4-Nonylphenol 1.0×10 -8 EC10 1,4, a 17β-Estradiol 3.0×10 -3 EC20 3,13, s 17β-Estradiol 1.0×10 +0 EC25 3,10, i 4-Nonylphenol 0.02 IC20 3,12, i 4-Nonylphenol 2.9×10 -2 ECIR1.5 3,14, a 17β-Estradiol 9.8×10 -4 ECIR1.5 3,15, v 
 Benzo(a)anthrac
ene 2.6×10 -5 EC25 1,5, b, c, d 4-Nonylphenol 3.0×10 -2 EC20 3,13, s 2,4'-DDE 6.3×10 -6 EC50 3,10, j 4-t-Octylphenol 0.34 IC20 3,12, i Atenolol 1.5×10 -3 ECIR1.5 3,14, u Apigenin 3.2×10 -3 ECIR1.5 3,15, r 
 
Benzo(a)pyrene 1.5×10 -4 EC20 1,6, e 4-t-Octylphenol 5.8×10 -2 EC20 3,13, s 2,4'-DDT 1.7×10 -5 EC25 3,10, i Acetochlor 0.62 IC20 3,12, r Atorvastatin 3.5×10 -2 ECIR1.5 3,14, u Benzo(a)pyrene 6.6×10 -2 ECIR1.5 3,15, r 
 Benzo(b) 
fluoranthene 4.6×10 -4 EC25 1,5, b, c, d Bezafibrate 6.2×10 -4 ECIR1.5 3,13, o 4,4'-DDD 6.8×10 -7 EC20 3,10, k Alachlor 0.83 IC20 3,12, r Atrazine 1.0×10 -2 ECIR1.5 3,14, u 
Benzo(b) 
fluoranthene 2.8×10 -3 ECIR1.5 3,15, r 
 
Benzo(e)pyrene 6.6×10 -7 EC25 1,5, b, c Bisphenol A 5.8×10 -3 EC20 3,13, s 4,4'-DDE 7.0×10 -7 EC50 3,10, j Benzo(a)pyrene 0.16 IC20 3,12, a 
Benzo(a)pyren
e 4.8×10 +0 ECIR1.5 3,14, a Benzo(e)pyrene 1.7×10 -3 ECIR1.5 3,15, r 
 Benzo(ghi)peryl
ene 2.6×10 -6 EC25 1,5, b Carbamazepine 4.6×10 -4 ECIR1.5 3,13, o 4,4'-DDT 1.3×10 -6 EC50 3,10, l Bisphenol A 1.20 IC20 3,12, a 
Benzo(b)fluora
nthene 8.4×10 +0 ECIR1.5 3,14, a 
Benzo(k) 
fluoranthene 4.0×10 -2 ECIR1.5 3,15, r 
 Benzo(j)fluorant
hene 5.5×10 -4 EC25 1,5, b, c Chlorpyrifos 3.1×10 -3 EC10 3,13, a 4-Nonylphenol 3.3×10 -6 EC20 3,10, k 
Bromocriptine 
mesylate 1.68 IC20 3,12, r Bisphenol A 1.5×10 -2 ECIR1.5 3,14, a Biochanin A 5.6×10 -4 ECIR1.5 3,15, r 
 Benzo(k) 
fluoranthene 3.1×10 -3 EC25 1,5, b, c, d Clotrimazole 4.3×10 -2 EC20 3,13, t 4-t-Octylphenol 1.1×10 -4 EC25 3,10, i Chloropyrifos 0.01 IC20 3,12, a Citalopram 3.0×10 -2 ECIR1.5 3,14, u Bisphenol A 7.1×10 -4 ECIR1.5 3,15, r 
 
Bisphenol A 1.4×10 -7 EC10 1,6, e Diazinon 1.1×10 -2 EC10 3,13, a 
Benzo(a) 
anthracene 7.9×10 -7 EC25 3,10, n Clotrimazole 2.23 IC20 3,12, r Genistein 2.7×10 -2 ECIR1.5 3,14, a Carbendazim 7.3×10 -3 ECIR1.5 
3,15, 
o 
 
Carbendazim 1.2×10 -8 EC10 1,6, e Diuron 4.3×10 -4 EC10 3,13, a Benzo(a)pyrene 4.7×10 -6 EC10 3,10, a Diazinon 0.02 IC20 3,12, e Metoprolol  3.0×10 -3 ECIR1.5 3,14, u Chlorprothixene 1.2×10 -3 ECIR1.5 3,15, r 
 
Chlorpyrifos 1.1×10 -7 EC10 1,4, a Estrone 4.1×10 -3 EC20 3,13, s 
Benzo(b) 
fluoranthene 3.4×10 -6 EC10 3,10, a Fenofibrate 0.59 IC20 3,12, r Propiconazole 2.7×10 -2 ECIR1.5 3,14, u Genistein 1.2×10 -3 ECIR1.5 
3,15, 
o 
 
Chrysene 6.5×10 -5 EC25 1,5, b,c Fenofibrate 2.5×10 -2 EC20 3,13, t Biochanin A 8.8×10 -5 EC50 3,11, m Ketoconazole 0.98 IC20 3,12, r    Prochloraz 7.2×10 -4 ECIR1.5 3,15, r 
 Cyclopenta(cd) 
pyrene 6.5×10 -7 EC25 1,5, c Genistein 1.2×10 -2 EC10 3,13, a Bisphenol A 4.4×10 -5 EC20 3,10, k Maprotiline 0.51 IC20 3,12, r         
 
Daidzein 1.1×10 -6 LOEC 2,8, f Isoproturon 1.6×10 -3 ECIR1.5 3,13, o Chlorpyrifos 2.8×10 -7 EC10 3,10, a Memantine 0.58 IC20 3,12, r         
 
Diazinon 1.0×10 -8 EC20 1,6, a Metolachlor 5.9×10 -2 EC10 3,13, a Chrysene 2.2×10 -6 EC25 3,10, q Metolachlor 0.02 IC20 3,12, e         
 
Diuron 1.8×10 -6 EC20 2,9, h o,p'-DDT 1.7×10 -2 EC20 3,13, s Daidzein 6.4×10 -5 EC50 3,10, o o,p-DDD 0.31 IC20 3,12, r    
     
 
Equol 1.0×10 -6 LOEC 2,8, f p,p'-DDD 4.1×10 -2 EC20 3,13, t Diazinon 2.9×10 -7 EC10 3,10, a Prochloraz 0.43 IC20 3,12, r    
     
 
Fluoranthene 9.3×10 -7 EC25 1,5, c p,p'-DDE 3.0×10 -2 EC20 3,13, t 
Donepezil 
hydrochloride 6.3×10 -5 EC10 3,11, p Propiconazole 0.07 IC20 3,12, a    
     
 
Genistein 7.9×10 -8 EC10 1,6, a p,p'-DDT 2.9×10 -2 EC20 3,13, t Equol 2.8×10 -4 EC50 3,10, i Triphenyl phosphate 0.03 IC20 3,12, a    
     
 
Prochloraz 2.3×10 -6 EC20 2,9, g PCB 101  3.4×10 -3 EC20 3,13, s Estriol 1.7×10 -1 EC25 3,10, i Temephos 0.41 IC20 3,12, r    
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Propiconazole 1.9×10 -5 EC50 2,8, h PCB 118 7.0×10 -3 EC20 3,13, t Estrone 1.1×10 -1 ECIR1.5 3,10, a TDCPPw 0.33 IC20 3,12, r    
     
 
Pyrene 4.1×10 -6 EC25 1,5, b,c PCB 138  5.3×10 -3 EC20 3,13, s Formononetin 2.3×10 -4 EC50 3,11, m 
Verapamil 
hydrochloride 0.27 IC20 3,12, r    
     
 
Terbuthylazine 1.3×10 -5 EC50 2,8, h PCB 153  6.0×10 -3 EC20 3,13, s Genistein 2.0×10 -4 EC10 3,10, a       
     
 
     PCB 180 6.0×10 
-3 EC20 3,13, s Naringenin 2.2×10 -5 EC50 3,11, m        
     
 
     Propiconazole 5.4×10 
-3 EC10 3,13, a Terbuthylazine 1.6×10 -7 EC10 3,10, a        
     
 
     Terbuthylazine 4.1×10 
-3 EC10 3,13, s 
Triphenyl 
phosphate 1.4×10 -6 EC10 3,10, a        
     
 
     
Triphenyl 
phosphate 1.7×10 -2 EC10 3,13, a             
     
 1 rat-based cell line 5 H4EII-luc 9 Hepa1c1c7 13HG5LN-hPXR a(Neale et al., 2017) e(current study) i(Kinani et al., 2010) m(Procházková et al., 2017) q(Lam et al., 2017) u(Escher et al., 2013) 
 
 
2 mouse-based cell line 6 H4G1.1c2 10 MELN 14AREc32 b(Larsson et al., 2012) f(Denison et al., 1998) j(Pillon et al., 2005) n(Machala et al., 2001) r (US EPA ToxCast) 
v (König et al., 2016)  
 
3 human-based cell line 7 H4L1.1c4 11 HeLa9903 15p53RE-bla 
c(M Machala et al., 
2001) 
g(Takeuchi et al., 2008) k(Creusot et al., 2013) o(Neale et al., 2015a) s (Creusot et al., 2010) 
wTris(1,3-Dichloro-2-
propyl)phosphate 
 
 
4 DR-CALUX 8 Hepa1.12cR 12 MDA-kb2  
d(Behnisch et al., 
2003) 
h(Ghisari et al., 2015) l(Leusch et al., 2010) p(Ceger et al., 2015) t(Creusot, 2011) 
xTris(2-butoxyethyl) 
phosphate 
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